rfhg_149585.1

Basic information about the TSS

---

TSS ID: rfhg_149585.1 Species: human Chr: chr12		Start: 45215677 End: 45215703 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2552663,EH38E1607180)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000426898.2:284 AK126409:284 GeneID: 196527 HGNC/MGI_ID: HGNC:25240 UniProt_ID: B3KX12 Nearer transcript ids and distances: ENST00000425752.6:317 AK310641:317 LF337715:-322 MA573292:-322 LF210415:344 MA445992:344 AK303996:353 ENST00000423947.7:382 AK302819:390 ENST00000680498.1:392 ENST00000320560.13:392 NM_001025356.3:392 NM_001204803.2:392 NM_001142679.2:392 ENST00000550630.5:417 BC098410:417 ENST00000680201.1:437 ENST00000681156.1:447 view more...

Gene_name: anoctamin 6 Gene_symbol: ANO6 Gene_synonyms: DKFZp313M0720 Gene_source: HGNC:25240

TATA-Box annotation

---

Distance to TSS:	316
Nearest PromoterID:	NR_037144
Entrez ID:	51054
Nearest Unigene:	Hs.233495
Nearest Refseq:	NM_015899
Nearest Ensembl:	ENSG00000134297
Gene Name:	anoctamin 6
Gene Alias:	FAPP-2|FAPP2|PLEKHA8|PLEKHA9|hFAPP2
Gene Type:	pseudo
CpG%:	0.038462
GC%:	0.518519
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ANO6 p2@ANO6 p3@ANO6 p4@ANO6 p5@ANO6 p6@ANO6
Sample		p1@ANO6	p2@ANO6	p3@ANO6	p4@ANO6	p5@ANO6	p6@ANO6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.32	4.09	2.34	1.36	0.97	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.34	2.83	1.62	0.20	1.01	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	10.80	2.89	0.77	1.16	1.35	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.86	2.70	2.08	1.46	0.42	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.92	2.25	2.92	0.90	1.57	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.66	4.07	1.74	1.16	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.33	2.18	1.74	2.18	0.87	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.87	7.51	2.18	0.73	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.04	2.35	2.56	1.50	1.50	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.85	1.74	4.06	0.58	2.90	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.11	1.62	2.83	0.40	2.02	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	4.47	5.29	1.22	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.83	9.83	4.19	2.74	1.13	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.80	8.72	2.71	1.95	1.65	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.54	8.78	4.39	2.20	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.86	6.04	4.53	2.77	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.63	8.08	2.18	1.97	1.97	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.72	5.91	4.22	0.84	1.69	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	6.93	4.27	2.13	1.60	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.55	6.02	3.91	1.96	1.20	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.17	7.89	4.41	3.21	2.81	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.71	6.73	3.28	2.07	1.04	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.23	6.85	4.78	2.07	1.94	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.77	5.10	3.15	2.67	1.94	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.67	8.51	4.64	1.55	1.81	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	7.91	4.75	1.90	2.22	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.84	5.49	5.49	3.30	3.85	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.74	8.02	4.48	3.54	3.30	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	17.61	8.72	3.88	1.78	1.94	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	19.36	9.41	4.71	2.53	3.80	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.52	7.96	5.23	2.72	2.72	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.91	8.60	3.52	1.76	3.52	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	18.78	8.02	4.22	1.90	2.32	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.78	7.92	6.10	2.47	2.31	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.19	8.23	5.98	2.80	4.49	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.35	9.39	7.09	4.41	2.68	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	17.58	6.95	4.91	2.25	2.45	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.94	7.05	4.63	1.81	3.43	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	27.28	6.48	5.94	3.51	4.05	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.53	11.28	4.32	3.36	3.12	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	23.53	9.41	6.12	3.06	2.82	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.93	7.76	5.56	3.37	2.34	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.15	10.54	6.96	2.53	4.43	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.27	11.89	4.72	4.20	2.97	3.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	28.91	11.04	6.22	1.81	3.21	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.43	9.77	5.35	3.49	3.26	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	25.43	10.56	4.56	5.04	2.88	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	26.53	9.24	5.66	2.68	2.98	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.77	8.86	8.14	5.03	2.63	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.66	10.92	6.87	3.24	3.84	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	33.41	14.14	10.04	5.53	6.56	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	33.58	11.79	9.56	5.34	6.23	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	83.95	55.97	0.00	27.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	38.32	17.03	7.10	4.61	5.32	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	28.83	11.93	7.95	3.65	5.30	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	56.21	27.68	26.01	6.71	8.39	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	27.10	11.48	5.97	2.76	5.51	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	33.38	17.18	11.67	3.89	9.08	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	35.33	13.81	10.28	3.21	8.35	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.86	14.46	8.49	3.14	4.71	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	47.24	14.81	4.94	1.41	6.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	33.65	17.38	6.17	5.05	7.29	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	41.40	27.07	15.13	8.76	7.96	7.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.10	11.21	8.49	3.40	4.76	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	42.56	20.47	12.67	7.15	11.70	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	32.30	9.58	6.03	4.26	7.10	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	96.98	32.33	32.33	32.33	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	86.87	47.38	31.59	55.28	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	31.20	13.65	6.34	3.41	2.93	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	27.27	9.92	5.45	3.47	5.95	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	7.04	7.04	4.69	2.81	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.18	8.28	6.29	1.99	3.64	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.72	7.11	4.02	2.17	2.17	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.94	12.84	4.59	2.14	3.97	1.22
Adipocyte - breast, donor1	11376-118A8	39.44	9.03	5.86	3.80	3.33	1.74
Adipocyte - breast, donor2	11327-117E4	25.51	6.26	13.64	2.41	5.45	2.25
Adipocyte - omental, donor1	11473-119C6	40.08	11.70	9.67	5.98	4.58	2.29
Adipocyte - omental, donor2	11474-119C7	28.40	6.73	0.75	1.49	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	26.46	6.03	9.04	2.34	1.34	0.33
Adipocyte - perirenal, donor1	11476-119C9	24.88	10.21	0.00	1.91	2.55	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	3.30	11.00	0.00	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	5.42	1.35	1.35	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	19.29	5.73	6.43	3.48	2.78	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	52.41	13.69	5.08	7.63	3.72	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	40.92	10.04	1.80	4.63	3.35	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	44.88	14.77	2.51	3.90	2.79	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	65.25	25.86	4.70	8.82	3.53	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	67.32	20.35	50.11	10.54	15.85	9.49
Adipocyte differentiation, day08, donor2	13023-139D8	57.45	20.01	14.52	7.75	6.46	3.23
Adipocyte differentiation, day08, donor3	13026-139E2	38.92	16.00	18.13	4.27	6.93	3.73
Adipocyte differentiation, day08, donor4	13029-139E5	54.53	22.81	26.71	7.23	7.23	8.90
Adipocyte differentiation, day12, donor1	13021-139D6	32.86	7.07	38.68	2.50	4.57	7.07
Adipocyte differentiation, day12, donor2	13024-139D9	36.92	8.29	16.83	4.77	5.27	2.76
Adipocyte differentiation, day12, donor3	13027-139E3	36.32	7.53	24.54	3.93	9.16	5.56
Adipocyte differentiation, day12, donor4	13030-139E6	45.37	18.27	51.15	5.78	11.27	10.66
Alveolar Epithelial Cells, donor1	11510-119G7	13.04	2.65	2.43	0.88	2.65	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.74	1.08	0.00	0.00	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	29.14	11.69	11.87	1.98	6.30	3.24
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	3.35	6.69	1.67	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	15.61	7.60	3.90	2.88	4.93	2.47
Anulus Pulposus Cell, donor1	11248-116E6	16.02	4.23	0.69	1.72	0.57	0.23
Anulus Pulposus Cell, donor2	11463-119B5	16.41	7.10	0.73	1.71	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	2.25	1.80	0.90	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.16	3.47	1.30	1.30	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	4.28	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.04	4.48	1.49	0.60	1.79	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	3.79	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	2.64	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.35	4.55	1.30	0.65	0.97	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.65	5.34	0.00	3.40	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	1.78	0.59	1.19	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.18	3.01	1.88	1.13	1.13	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	5.81	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.97	5.44	0.66	1.48	0.99	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	4.09	1.36	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.36	3.92	1.06	1.06	1.06	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.68	2.68	0.54	0.54	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.90	5.10	0.38	1.51	0.76	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	4.01	2.67	1.60	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	21.46	6.83	0.98	3.90	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.76	4.31	0.50	1.99	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	7.20	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	3.54	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.89	3.43	0.69	2.74	1.20	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	4.85	0.00	1.94	0.49	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.14	4.17	0.00	2.66	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	1.21	1.21	2.42	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	16.53	5.13	0.57	2.85	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.40	2.78	1.07	1.07	0.64	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	4.13	1.03	0.52	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	3.28	0.47	0.94	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.29	3.22	1.61	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	2.85	0.00	0.71	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	2.92	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.14	3.01	1.20	3.01	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.71	3.05	0.00	0.51	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.26	5.60	0.51	0.25	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	0.00	0.64	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.22	1.73	1.73	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.07	3.60	1.27	2.12	0.64	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.73	4.93	0.29	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	4.72	0.00	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.07	4.58	1.02	1.36	1.53	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32	2.32	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	2.11	0.00	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	17.80	3.22	0.43	2.14	0.64	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	5.41	1.80	2.41	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	1.46	1.46	3.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.79	4.60	0.46	1.38	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	0.00	0.00	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.69	2.54	0.51	0.76	2.03	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.04	4.95	0.41	2.68	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.10	2.14	0.92	1.84	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	14.34	4.78	0.96	2.87	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.97	4.21	0.44	0.67	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	1.53	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.63	1.11	1.11	1.11	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.56	3.44	0.53	1.59	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.81	2.91	0.00	2.18	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	12.04	5.65	1.72	0.86	1.11	0.74
Astrocyte - cerebellum, donor2	11580-120F5	8.90	3.42	1.54	0.17	0.86	1.20
Astrocyte - cerebellum, donor3	11661-122F5	5.24	2.52	0.63	1.89	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	16.73	7.67	4.18	5.23	2.09	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	16.18	6.96	1.62	2.26	1.46	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	22.67	7.76	3.28	3.58	2.68	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	27.30	8.95	1.95	1.83	1.03	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	28.44	4.64	1.88	1.88	1.00	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	22.87	7.40	1.25	1.48	1.02	0.91
Basophils, donor1	12241-129G9	21.45	4.97	0.52	1.31	0.26	0.52
Basophils, donor2	12242-129H1	47.62	10.82	1.44	3.25	2.16	0.36
Basophils, donor3	12243-129H2	36.60	8.82	0.88	2.06	2.50	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	5.82	1.72	0.22	0.86	0.65	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.91	0.00	1.37	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	2.51	0.00	0.63	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	16.64	6.24	1.66	1.66	1.25	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	10.59	2.53	0.46	1.38	0.46	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	13.50	5.94	0.72	1.62	0.54	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.00	5.05	1.44	1.75	2.27	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.10	5.82	1.16	2.10	0.93	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.62	6.72	0.64	1.28	1.92	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	64.81	19.72	2.82	2.25	9.02	2.25
CD14+ Monocytes, donor2	11305-117B9	51.23	10.02	4.08	2.97	5.01	1.67
CD14+ Monocytes, donor3	11381-118B4	48.08	10.98	3.29	2.63	4.83	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	90.29	30.00	1.70	3.40	1.13	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	72.02	25.40	2.27	3.41	1.52	3.03
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	100.92	38.46	3.29	5.59	2.30	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	28.48	4.77	1.73	2.31	2.02	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	37.72	7.24	2.72	1.21	4.22	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	43.11	11.37	1.90	2.84	2.84	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.46	6.19	3.01	2.18	3.01	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	38.37	9.38	3.59	1.93	2.48	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	35.95	8.18	3.72	3.22	2.73	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	43.27	8.62	5.48	4.50	2.94	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	53.24	11.40	8.72	4.63	5.88	2.49
CD14+ monocytes - treated with BCG, donor3	11880-125C8	58.32	15.02	7.18	2.39	5.44	3.48
CD14+ monocytes - treated with Candida, donor1	11868-125B5	55.72	12.41	13.11	3.98	11.47	4.68
CD14+ monocytes - treated with Candida, donor2	11878-125C6	69.17	19.01	6.86	4.22	6.34	4.75
CD14+ monocytes - treated with Candida, donor3	11888-125D7	55.47	9.98	6.66	3.33	5.55	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	27.52	6.69	1.49	2.08	2.23	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	33.72	9.98	3.99	2.79	4.59	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	29.98	9.58	3.12	2.91	4.16	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	54.22	10.98	10.07	3.66	5.72	3.43
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	58.59	10.86	12.22	3.62	6.79	1.58
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	47.14	14.40	10.48	4.80	4.80	3.49
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	56.76	9.68	4.57	4.03	4.84	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	54.43	14.13	7.33	3.49	4.88	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	58.91	13.89	9.68	8.00	5.89	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	48.32	11.02	7.90	2.76	4.78	1.84
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	67.99	20.08	5.28	4.93	7.75	2.47
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	54.84	14.04	13.16	5.26	8.77	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	44.47	9.07	4.71	2.96	4.36	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	51.66	11.89	5.95	3.35	6.32	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	59.06	14.66	11.21	2.80	5.39	3.23
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	48.73	10.24	4.91	2.87	6.96	3.69
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	56.33	13.21	5.79	2.09	5.33	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	54.98	12.06	6.50	2.32	3.94	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	36.18	11.12	0.44	1.53	1.74	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	35.34	5.08	0.23	0.92	0.92	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	25.99	7.36	0.65	1.30	1.95	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	62.29	11.52	0.47	1.71	2.02	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	46.46	10.30	1.22	0.87	1.57	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	103.68	22.30	1.34	4.46	4.91	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	27.05	6.38	0.26	1.02	1.02	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	23.49	5.27	0.44	0.66	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	23.79	5.90	0.42	0.42	0.21	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	17.63	9.49	0.68	0.68	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	15.53	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	22.39	9.59	1.60	3.20	2.13	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	19.30	11.79	0.00	2.68	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	28.08	4.91	0.00	1.40	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	24.31	7.84	0.00	1.57	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	3.95	0.00	2.64	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	25.48	4.93	0.00	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	11.61	11.61	0.00	2.90	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	19.18	10.10	0.00	1.51	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.27	2.02	2.42	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	4.79	1.20	0.40	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	18.07	2.01	2.01	3.01	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	22.47	8.43	2.25	1.69	3.37	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	23.67	10.52	0.38	1.50	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.35	5.19	0.68	2.03	1.13	1.35
CD4+ T Cells, donor1	11225-116C1	49.99	17.50	0.36	1.07	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	28.78	7.35	0.00	0.61	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	34.16	13.72	0.30	2.13	1.52	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	30.37	10.46	1.02	2.55	1.28	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.71	11.01	0.45	1.57	0.67	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	31.91	9.77	1.44	2.01	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.23	15.17	0.47	0.95	1.42	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	27.39	13.34	0.00	2.11	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	9.89	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	30.93	10.84	1.01	2.31	1.30	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	27.28	8.81	1.02	2.37	1.69	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.18	7.90	0.97	1.29	1.29	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	23.31	4.48	0.45	2.69	1.79	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	29.00	10.83	2.45	2.80	1.75	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	28.16	11.44	0.44	3.08	1.76	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	22.77	7.59	1.69	3.79	1.69	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	21.40	5.61	0.21	0.83	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	18.04	6.01	0.33	1.00	1.34	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.64	11.97	0.00	2.18	0.82	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	10.18	0.54	2.14	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	28.69	7.17	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	36.53	11.13	1.30	3.15	2.60	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.26	10.61	1.95	2.60	1.95	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.78	10.93	0.84	1.68	0.84	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	21.74	13.15	0.51	3.54	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	23.83	13.00	0.43	1.30	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	28.33	19.61	0.44	2.61	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	35.63	20.29	0.00	3.46	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	12.92	0.00	2.77	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	12.56	0.00	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	43.75	20.77	0.28	2.77	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	43.92	25.03	0.25	3.68	1.23	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	47.74	18.48	0.00	1.54	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	37.24	17.91	0.00	5.01	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	23.54	15.23	0.00	5.54	1.38	4.15
CD8+ T Cells, donor1	11226-116C2	26.52	11.79	0.65	0.33	1.31	0.33
CD8+ T Cells, donor2	11307-117C2	21.78	7.88	1.13	1.88	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	24.49	8.58	0.00	1.01	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.09	1.61	0.46	0.69	1.15	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.67	2.64	0.72	0.24	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.03	2.46	0.82	0.27	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.71	3.00	0.30	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	1.92	0.00	0.24	0.72	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.87	1.14	1.14	0.00	0.91	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.34	2.61	0.43	0.43	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.26	3.42	1.84	0.53	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.37	2.58	0.70	1.41	0.94	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.89	3.62	0.60	0.60	0.60	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	12.78	1.45	1.45	2.03	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.99	3.20	0.80	1.07	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.45	4.38	0.44	0.44	2.19	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	13.21	4.55	1.82	0.46	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.88	2.98	0.75	1.49	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.25	2.88	0.36	1.08	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.63	3.74	0.58	0.58	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.54	1.41	0.47	0.71	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.48	4.44	1.27	1.90	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	14.46	2.77	1.54	0.62	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.90	1.92	0.64	1.92	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	15.30	3.06	1.15	0.00	1.53	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	12.22	1.58	0.79	0.39	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	11.35	3.03	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	4.82	1.61	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.28	4.90	3.50	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	5.01	1.00	2.00	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	56.66	25.59	5.48	7.31	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	12.35	4.94	0.49	0.99	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	26.31	10.10	3.68	5.16	2.74	1.05
Chondrocyte - de diff, donor1	11261-116G1	15.60	7.63	1.39	2.08	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	13.50	3.91	1.07	2.49	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	12.06	3.53	0.34	1.93	0.91	0.11
Chondrocyte - re diff, donor2	11339-117F7	30.44	6.27	0.00	4.48	1.79	0.90
Chondrocyte - re diff, donor3	11411-118E7	19.41	5.26	1.21	4.85	1.62	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	35.35	11.93	3.79	5.62	1.95	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	23.73	6.41	2.35	2.99	1.50	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	23.98	8.67	2.74	3.54	1.42	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	46.40	15.41	11.00	3.58	3.30	3.03
Corneal Epithelial Cells, donor1	11526-119I5	5.49	1.10	0.66	0.66	0.66	0.44
Corneal Epithelial Cells, donor2	11606-120I4	6.83	3.41	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	5.88	1.79	0.77	1.28	0.77	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	83.54	13.70	1.49	2.81	2.97	2.31
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	73.81	11.35	1.89	1.58	4.42	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	0.00	0.00	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	36.61	8.42	1.08	1.73	0.97	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.85	10.93	1.71	2.39	1.37	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	38.52	9.79	0.00	0.65	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	27.58	9.68	0.48	2.90	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	25.68	8.84	2.84	4.17	3.00	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	18.78	6.45	2.93	1.76	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	30.54	5.66	3.39	1.98	3.11	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	38.93	5.90	5.50	6.29	4.33	1.18
Endothelial Cells - Artery, donor1	11264-116G4	18.62	4.94	1.75	1.75	1.16	0.29
Endothelial Cells - Artery, donor2	11341-117F9	20.94	7.29	2.35	1.65	3.06	0.94
Endothelial Cells - Artery, donor3	11413-118E9	19.99	5.26	2.10	2.80	1.05	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	48.54	12.41	4.21	4.88	5.10	1.77
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.29	14.60	2.43	5.78	3.04	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	69.07	16.35	3.10	6.20	5.07	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	19.61	5.65	0.59	1.78	2.38	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	24.99	3.12	0.52	1.04	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	8.93	3.12	0.99	1.13	1.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	38.81	9.20	2.80	3.60	5.60	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	14.68	6.29	0.52	1.57	1.57	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.69	15.03	3.60	5.47	8.08	2.98
Endothelial Cells - Umbilical vein, donor2	11324-117E1	55.84	14.12	2.61	3.26	4.35	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	66.56	15.88	3.91	5.37	7.82	2.56
Endothelial Cells - Vein, donor1	11267-116G7	26.16	5.69	5.69	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	30.04	11.18	1.40	0.70	3.49	0.70
Endothelial Cells - Vein, donor3	11416-118F3	28.26	6.59	2.04	2.67	3.30	0.47
Eosinophils, donor1	12244-129H3	167.72	30.49	0.00	30.49	15.25	0.00
Eosinophils, donor2	12245-129H4	9.90	0.00	1.65	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	3.57	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.86	1.71	0.73	0.24	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	8.32	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	31.20	12.32	3.69	6.16	3.69	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.98	2.30	1.86	0.88	0.88	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	3.36	1.30	0.98	0.65	1.19	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	25.95	7.28	5.34	3.64	3.15	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.71	9.14	2.87	3.28	0.96	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.25	6.64	2.85	3.16	2.21	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	52.96	19.23	3.95	5.27	3.43	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.93	5.32	2.66	1.66	2.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	15.88	8.62	2.27	2.72	2.72	0.91
Fibroblast - Cardiac, donor2	11345-117G4	19.71	4.55	2.27	5.31	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	11.51	3.31	2.21	2.21	0.63	0.63
Fibroblast - Cardiac, donor4	11452-119A3	41.22	14.25	7.58	7.27	5.76	1.82
Fibroblast - Cardiac, donor5	11456-119A7	28.17	9.14	2.03	3.17	1.40	0.38
Fibroblast - Cardiac, donor6	11460-119B2	26.53	7.88	1.82	2.73	3.18	1.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	18.22	8.44	0.54	1.74	0.27	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.36	12.51	2.59	2.59	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	2.93	1.46	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.15	4.15	2.31	1.85	0.69	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	36.80	10.52	2.20	4.41	1.02	1.36
Fibroblast - Dermal, donor1	11269-116G9	10.57	4.46	0.47	1.64	1.41	0.47
Fibroblast - Dermal, donor2	11346-117G5	9.91	8.02	1.89	1.42	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	13.18	2.66	0.24	2.30	1.09	0.24
Fibroblast - Dermal, donor4	11450-119A1	24.98	6.33	1.92	1.81	1.02	1.13
Fibroblast - Dermal, donor5	11454-119A5	26.34	8.02	1.74	1.92	1.40	1.05
Fibroblast - Dermal, donor6	11458-119A9	24.85	6.17	2.27	2.11	1.95	1.62
Fibroblast - Gingival, donor1	11237-116D4	20.41	7.08	0.42	2.50	1.46	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	26.99	7.34	3.41	1.83	0.79	1.31
Fibroblast - Gingival, donor2	11318-117D4	14.50	5.80	1.05	1.98	1.32	0.53
Fibroblast - Gingival, donor3	11394-118C8	28.91	9.67	1.84	2.51	1.26	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	4.16	1.04	3.12	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.86	4.05	1.06	2.11	0.35	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.58	4.68	1.71	2.34	1.87	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.15	4.46	1.49	1.08	0.95	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	28.94	9.17	7.41	2.47	2.12	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	20.47	4.39	1.75	1.17	1.61	1.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.00	4.36	1.64	2.59	1.64	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	19.74	5.59	3.95	1.32	2.85	1.86
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.58	10.42	2.64	4.11	0.88	0.73
Fibroblast - Lung, donor1	11270-116H1	10.87	2.72	0.00	0.00	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	37.30	8.95	1.49	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	15.62	3.38	1.27	2.11	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	23.32	3.33	1.67	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	1.40	0.00	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.32	0.84	0.00	0.00	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	24.76	8.12	2.44	0.81	2.44	1.62
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	26.38	6.98	1.16	2.91	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.63	8.95	2.58	2.28	1.82	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.93	9.79	1.84	2.75	1.84	3.06
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.48	9.92	1.14	3.82	1.91	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.04	2.97	1.35	2.97	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.63	8.35	1.04	2.55	0.81	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.23	6.30	2.32	1.88	1.77	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	22.76	5.69	1.63	0.81	2.24	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	2.67	0.00	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.91	4.35	0.40	1.19	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	50.41	11.31	3.77	2.18	2.98	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.53	11.37	0.89	3.55	1.95	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.50	13.01	1.97	3.74	1.38	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	41.82	13.24	2.71	1.20	2.41	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	38.75	13.71	1.73	3.56	0.97	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	34.67	11.39	1.27	1.01	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	34.95	9.84	1.64	3.12	2.30	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	67.17	18.85	7.22	5.01	4.21	2.41
Fibroblast - skin normal, donor2	11561-120D4	34.26	9.24	2.71	2.71	2.21	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	34.15	13.90	2.12	3.63	1.51	2.42
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	47.22	12.59	2.73	4.97	2.15	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.87	15.21	2.05	5.47	3.08	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	51.89	19.71	3.61	5.25	1.31	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	35.26	11.29	2.24	3.52	2.77	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	28.34	7.76	1.18	3.20	0.84	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.80	7.84	2.35	0.63	0.78	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	0.00	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	4.36	0.87	4.36	3.49	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.13	13.18	10.57	3.47	10.23	4.33
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	53.61	14.31	9.63	5.47	9.63	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	52.38	13.03	12.01	6.13	7.92	4.60
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.08	3.83	0.00	2.30	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	4.47	0.64	0.64	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	19.40	7.70	3.71	3.42	2.57	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	19.03	10.20	1.93	1.38	1.10	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	12.33	4.34	4.34	1.37	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	18.43	7.33	4.56	1.59	3.17	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	20.35	7.14	3.44	1.32	1.32	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	25.11	9.78	4.89	2.94	2.28	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	22.55	9.29	4.42	2.21	5.75	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.42	9.61	2.26	2.54	1.84	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	31.03	10.71	1.85	1.72	2.34	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.46	9.13	1.88	1.07	1.88	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	28.99	8.67	2.11	2.73	2.23	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	41.53	12.32	3.18	3.18	2.91	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	29.07	9.76	3.46	3.46	1.63	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	20.31	8.44	2.51	2.28	0.91	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.24	12.21	3.99	3.61	3.49	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	56.17	15.52	6.56	6.12	4.59	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.34	7.09	2.07	1.77	0.59	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	30.36	9.54	1.43	2.86	1.75	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.29	10.05	4.24	2.90	3.80	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.20	6.86	3.02	3.02	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.24	8.82	1.02	2.04	1.19	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	47.08	12.06	3.46	4.34	3.19	2.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	33.71	10.61	0.83	4.06	1.66	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	33.30	9.56	1.54	2.05	0.51	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.79	9.07	1.55	1.88	1.88	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.35	12.23	2.75	5.66	3.16	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.75	12.05	2.86	4.29	2.45	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	18.36	6.60	0.83	1.44	0.62	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.13	10.15	1.04	3.34	0.92	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	24.68	9.67	1.83	2.33	0.33	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.96	7.49	1.32	1.76	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.69	9.96	1.11	2.58	1.11	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.02	10.37	2.11	3.40	1.30	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.41	8.66	0.64	1.60	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.79	6.16	1.61	1.71	0.57	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.46	6.33	2.21	1.74	0.47	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.68	4.87	1.52	1.22	0.91	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	24.67	8.78	1.25	3.14	1.57	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.71	9.22	1.98	2.63	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.92	5.61	1.40	1.12	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.09	7.04	2.13	2.87	1.94	2.13
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.39	5.35	1.07	1.87	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	16.98	5.81	2.30	2.14	1.68	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.86	5.05	1.94	2.07	1.17	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.96	8.13	1.08	1.90	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.76	9.40	2.77	3.13	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	29.17	9.65	2.41	2.63	3.07	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	49.59	10.91	4.96	4.96	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.55	9.63	2.64	4.22	1.85	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	35.51	11.10	1.41	3.63	1.41	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	57.95	14.74	6.10	7.88	1.78	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	33.44	16.12	1.99	4.18	0.80	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.35	10.94	1.23	3.70	1.69	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	26.19	13.30	1.64	4.09	1.23	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.45	2.50	0.94	1.25	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	8.76	1.70	0.57	0.85	1.13	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.06	5.53	1.38	0.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	7.42	0.00	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.86	5.03	3.09	2.32	2.71	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	3.21	3.21	1.60	4.81	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	5.22	0.00	1.74	5.22	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.62	2.93	1.95	2.60	2.60	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	25.12	7.41	7.00	1.65	2.06	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	10.00	0.00	10.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	20.41	9.79	3.36	2.24	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	21.90	6.86	3.92	3.60	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	22.65	10.90	5.87	3.36	5.03	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	26.40	9.86	4.13	3.50	1.59	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.34	3.74	2.04	4.08	1.70	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	10.44	6.26	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	25.77	8.59	1.72	1.72	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.24	5.03	1.48	2.37	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	28.80	1.69	5.08	5.08	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.89	6.21	5.80	3.73	2.07	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.94	5.98	4.37	2.07	2.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	15.81	10.54	10.54	5.27	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	20.76	5.77	4.23	2.31	2.69	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	31.29	5.87	3.91	2.28	2.28	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	24.75	7.36	9.36	2.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	36.22	7.32	1.54	4.24	2.31	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	44.50	10.27	6.85	5.48	4.45	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	12.42	2.48	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	32.09	9.44	1.89	2.36	1.89	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	32.59	8.45	2.41	4.22	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.15	11.70	4.07	2.03	1.53	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	32.70	10.77	4.79	6.78	1.99	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	37.50	9.37	4.44	3.45	2.47	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	41.32	14.17	3.54	3.54	2.36	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	27.42	10.50	2.33	4.67	2.33	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	39.50	13.17	0.88	2.63	1.76	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	40.69	14.41	2.54	2.54	2.54	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	18.50	10.15	1.79	4.18	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	20.38	6.79	1.46	1.94	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	10.27	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.23	4.57	1.66	3.33	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	5.62	1.12	4.50	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.49	6.98	0.00	3.81	1.27	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	5.01	1.25	0.42	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	8.82	2.20	1.51	0.70	1.51	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.80	3.21	1.52	0.51	1.69	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.01	2.28	1.37	0.91	1.37	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.48	2.19	1.20	0.87	0.87	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.53	2.58	1.50	0.21	2.15	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.41	1.72	0.86	0.43	0.43	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.96	3.61	1.62	0.62	0.50	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.81	3.77	0.69	0.34	1.89	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.49	1.60	1.92	0.96	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.59	3.92	0.56	2.24	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.79	3.03	0.00	0.43	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	2.64	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.05	4.59	0.71	1.06	1.41	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.08	1.45	0.00	1.45	2.91	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.49	1.92	1.75	0.87	1.05	0.17
Hepatocyte, donor1	11523-119I2	65.37	19.37	24.21	7.26	2.42	2.42
Hepatocyte, donor2	11603-120I1	66.79	18.31	6.46	5.39	0.00	2.15
Hepatocyte, donor3	11684-122I1	69.94	25.16	9.20	6.14	3.07	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	62.01	11.75	7.83	3.92	11.75	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	81.45	29.01	13.81	7.87	5.94	2.80
Iris Pigment Epithelial Cells, donor1	11530-119I9	19.07	6.45	2.74	3.29	2.61	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	3.18	3.18	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	0.00	1.38	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	2.50	2.50	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	5.29	1.32	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	2.22	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.93	0.63	1.89	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	4.64	3.09	3.09	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	13.57	3.88	1.29	0.00	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	11.41	0.81	0.81	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	3.36	0.42	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	6.43	1.61	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	2.77	1.85	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.61	1.42	0.94	0.00	1.89	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	2.72	0.91	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	10.76	2.15	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	1.27	0.00	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.29	4.46	0.64	2.55	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	1.82	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	0.71	1.43	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.40	0.62	0.00	0.31	0.93	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.13	3.48	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	0.00	0.00	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	2.62	0.00	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	18.14	6.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	2.77	0.00	1.39	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	0.00	2.76	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	3.03	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	28.23	5.71	6.45	2.45	6.36	2.53
Keratinocyte - epidermal, donor2	11349-117G8	5.86	2.34	1.76	0.59	0.59	1.17
Keratinocyte - epidermal, donor3	11421-118F8	27.26	5.77	3.98	2.56	5.02	1.99
Keratinocyte - oral, donor1	11251-116E9	40.98	12.71	2.84	3.18	3.18	2.16
Keratocytes, donor1	11527-119I6	13.41	4.47	1.38	1.72	0.34	0.00
Keratocytes, donor2	11607-120I5	7.03	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	22.13	8.50	1.19	2.77	0.40	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	94.51	50.55	0.00	8.79	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	6.47	6.47	0.00	2.16	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	26.07	11.88	1.15	3.00	1.04	0.23
Lens Epithelial Cells, donor3	11690-122I7	47.93	14.13	7.37	6.16	3.83	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.60	5.93	0.83	1.19	1.66	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.65	1.40	0.28	1.12	1.12	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.73	3.46	1.26	1.73	0.94	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.37	2.15	1.61	0.00	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	1.89	0.32	1.58	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.55	2.05	0.32	0.65	0.75	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.88	2.05	0.41	2.05	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.57	0.76	0.00	0.76	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.71	2.11	0.42	1.13	0.99	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	2.77	0.79	1.58	0.40	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	2.91	0.39	0.58	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.37	1.11	0.00	0.56	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.50	3.14	1.39	1.39	1.39	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	8.59	2.86	0.48	1.91	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.38	1.65	0.55	1.24	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.39	2.46	0.31	2.46	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.68	0.00	0.94	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.70	2.20	1.46	0.55	0.91	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.82	4.28	0.33	0.00	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	2.05	0.88	1.17	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.47	1.24	0.75	0.75	1.24	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.58	3.39	1.94	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.69	1.89	0.27	0.54	0.81	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.96	3.78	1.21	1.67	0.76	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	1.56	0.00	0.52	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.73	3.14	0.42	1.47	1.88	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	11.28	2.56	0.90	1.50	0.75	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	6.19	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.03	0.75	0.94	0.56	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.00	2.33	0.95	0.32	0.64	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.72	1.94	0.97	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.63	1.65	0.66	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.68	1.61	0.62	1.24	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.25	4.07	1.11	3.33	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.41	1.48	0.49	1.24	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.19	1.65	0.55	0.69	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.15	5.15	1.93	1.61	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.91	3.04	1.22	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.78	3.50	1.96	2.10	0.98	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.22	4.27	0.71	0.71	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.36	1.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.67	0.93	0.31	0.31	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.97	2.86	0.72	1.79	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.80	1.96	0.00	0.33	1.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.53	0.94	0.47	0.47	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.59	4.08	0.99	1.61	1.11	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.10	1.02	0.26	0.51	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.35	3.28	0.90	0.60	2.09	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	2.27	2.27	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	3.07	3.07	0.00	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	3.71	3.71	0.74	1.48	4.45
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.00	3.81	2.96	0.85	1.27	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	0.70	0.00	0.00	0.00	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	0.93	4.67	0.00	1.87	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	4.12	1.55	0.00	3.09	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	14.27	2.38	5.95	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.02	2.94	2.04	1.13	1.58	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.51	2.91	4.65	0.29	2.04	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.00	4.50	3.15	0.90	2.25	3.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.72	4.06	4.61	1.63	4.06	1.63
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.38	3.59	3.59	0.51	2.57	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	4.23	4.59	1.06	3.18	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	1.33	2.67	0.67	2.00	5.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.30	2.04	4.08	0.51	4.08	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.87	4.27	2.93	1.07	2.93	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	16.63	4.16	3.59	1.51	3.59	3.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.02	2.45	3.07	0.00	1.84	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	8.15	7.34	0.82	1.63	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.08	4.37	3.96	0.83	4.58	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.97	3.36	3.64	0.84	1.96	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	7.21	6.18	1.03	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.87	5.23	3.77	1.45	4.06	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.05	3.59	4.48	0.90	4.78	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.70	1.66	4.43	0.00	4.43	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13.08	3.89	3.89	1.41	2.47	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.38	4.06	4.06	1.11	3.69	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	17.27	4.61	3.45	0.00	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	18.42	3.84	4.61	1.15	4.61	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	1.13	3.96	1.13	4.53	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	4.92	3.28	0.00	3.28	4.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.10	3.62	2.26	0.00	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	16.52	5.03	4.31	0.72	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	2.24	3.73	0.75	2.24	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.03	1.49	3.34	0.37	4.46	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.65	4.31	3.02	1.72	2.15	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	2.57	3.43	1.71	0.86	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.99	3.66	3.66	1.00	2.33	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.07	3.62	4.22	0.00	2.41	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	3.55	2.84	2.13	2.13	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.53	4.81	5.84	0.69	2.06	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.05	2.68	5.37	0.00	2.68	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.85	4.04	4.04	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.04	4.44	3.70	1.48	1.85	4.07
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	1.16	3.49	0.00	4.65	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	4.23	6.35	1.06	4.23	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.81	2.40	3.20	1.20	2.80	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.99	3.63	2.18	0.00	1.45	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	3.07	4.60	1.53	3.07	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.81	3.45	0.49	1.48	0.49	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	2.82	10.35	0.94	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	10.56	4.53	2.51	1.01	5.03	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.12	4.96	2.25	1.80	1.35	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	1.72	0.00	0.00	1.72	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.03	3.12	5.34	0.89	2.67	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.81	4.30	6.65	0.39	5.08	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	2.64	4.62	0.00	3.30	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.09	5.71	6.23	1.04	3.11	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.94	3.06	4.38	2.19	2.63	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.21	2.80	6.15	1.68	1.68	6.15
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	21.20	2.21	3.09	1.32	4.86	5.74
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.81	4.24	5.40	1.16	3.86	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	3.04	7.09	1.01	3.04	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.90	6.25	5.77	1.44	1.92	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.50	3.58	5.57	1.19	1.99	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	3.65	5.47	0.61	4.86	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.07	3.46	4.84	2.08	1.38	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.14	4.94	3.80	0.76	3.42	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.62	6.20	4.65	2.07	3.10	4.65
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.95	6.05	3.02	2.42	3.02	4.23
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	17.75	3.17	6.34	1.27	6.34	2.85
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	5.33	8.00	1.07	5.86	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.09	4.60	2.30	0.57	4.02	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	15.43	6.69	5.66	1.54	3.60	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	8.49	4.95	1.41	2.12	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.19	2.27	6.24	0.57	3.97	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	3.74	2.08	0.83	3.33	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15.66	2.35	7.05	0.78	4.70	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.53	2.51	4.18	0.42	2.92	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.40	3.25	4.18	1.39	3.72	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	11.37	4.68	8.03	0.00	2.68	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	23.52	3.74	3.74	0.53	3.74	8.55
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.49	4.85	4.85	0.40	3.23	6.87
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	3.67	4.59	0.92	0.00	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	12.45	8.00	4.45	0.00	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	5.70	1.14	0.00	4.56	3.42
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	3.83	6.90	0.77	3.07	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	23.53	6.02	6.02	0.00	3.28	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.93	3.12	3.56	0.45	3.56	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	18.46	4.16	4.68	1.82	3.12	3.64
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.26	3.32	3.98	0.66	3.32	5.97
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	2.08	4.16	0.00	6.24	2.08
Macrophage - monocyte derived, donor1	11232-116C8	62.90	19.60	0.91	3.42	1.37	1.60
Macrophage - monocyte derived, donor2	11313-117C8	46.24	11.38	1.65	1.84	2.02	1.10
Macrophage - monocyte derived, donor3	11389-118C3	46.40	12.71	1.57	1.57	2.36	1.57
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.65	7.43	6.37	2.66	4.25	2.66
Mallassez-derived cells, donor2	11929-125I3	61.95	16.64	9.03	7.13	10.62	3.64
Mallassez-derived cells, donor3	11930-125I4	43.36	10.01	7.92	3.89	5.84	2.64
Mammary Epithelial Cell, donor1	11273-116H4	27.10	6.98	5.28	3.29	3.39	1.59
Mammary Epithelial Cell, donor2	11350-117G9	15.93	5.79	3.19	0.87	3.47	1.45
Mammary Epithelial Cell, donor3	11422-118F9	10.97	2.24	1.75	2.00	2.74	0.75
Mast cell - stimulated, donor1	11487-119E2	15.59	6.10	0.68	3.39	1.36	1.36
Mast cell, donor1	11563-120D6	19.47	4.76	0.43	2.05	0.54	0.00
Mast cell, donor2	11565-120D8	27.04	8.92	0.59	2.08	1.19	0.00
Mast cell, donor3	11566-120D9	29.04	11.93	0.68	1.35	1.13	0.90
Mast cell, donor4	11567-120E1	33.15	9.40	1.06	1.06	1.60	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	28.06	7.21	0.89	1.55	0.67	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	22.76	5.84	1.75	0.58	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	20.99	7.11	0.34	1.26	0.80	0.57
Mast cell, expanded, donor8	11941-126A6	33.47	8.03	0.33	1.34	0.33	0.33
Melanocyte - dark, donor1	11502-119F8	22.49	6.77	0.90	2.49	1.39	0.20
Melanocyte - dark, donor2	11582-120F7	18.00	2.77	0.35	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	24.27	7.39	2.17	2.46	2.03	1.74
Melanocyte - light, donor1	11274-116H5	20.22	5.64	0.47	1.41	1.65	0.24
Melanocyte - light, donor2	11351-117H1	11.60	2.73	2.05	1.36	0.68	1.36
Melanocyte - light, donor3	11423-118G1	4.34	3.47	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.43	6.77	1.46	2.29	1.98	1.77
Melanocyte, donor2 (MC+2)	12739-135I3	22.05	4.84	1.61	2.15	3.23	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	21.70	10.45	1.34	4.02	0.54	0.27
Meningeal Cells, donor1	11493-119E8	22.21	8.06	1.49	1.61	1.98	0.87
Meningeal Cells, donor2	11573-120E7	19.81	7.92	2.20	3.52	0.88	0.44
Meningeal Cells, donor3	11654-122E7	20.70	6.19	2.28	2.93	2.53	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	13.12	2.85	0.00	0.86	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	32.60	9.66	3.62	3.42	3.42	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	0.00	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	7.89	4.31	0.72	2.15	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	33.67	11.65	5.93	2.75	4.02	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	20.11	6.03	0.50	2.01	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.47	1.54	0.66	0.22	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.19	2.19	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.14	1.64	0.20	0.00	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	25.49	9.42	0.69	1.80	0.83	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.09	2.23	0.37	0.74	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	38.42	10.92	2.24	3.42	1.71	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.20	3.26	0.30	0.30	0.89	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.20	8.51	3.90	1.42	2.48	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.77	8.44	0.31	3.75	1.56	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.08	2.90	0.00	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	21.48	7.96	0.80	3.71	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	14.51	7.01	1.00	4.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	19.73	5.93	0.94	2.31	0.94	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	132.33	32.41	1.35	6.75	4.05	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	59.11	16.99	2.22	2.96	1.23	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	43.29	10.60	2.06	2.06	2.94	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	200.51	20.74	0.00	10.37	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	50.21	11.16	0.93	2.17	1.24	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.63	7.26	1.66	0.62	1.66	1.87
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	150.54	27.79	0.00	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	40.54	11.26	1.00	2.25	1.25	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.48	12.10	3.26	1.40	2.79	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	233.59	0.00	0.00	38.93	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	32.31	10.36	1.63	1.63	1.42	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.05	6.73	3.56	1.58	2.77	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	196.68	17.10	8.55	25.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	38.05	4.42	0.88	0.88	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	22.42	7.60	1.52	0.00	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	115.80	32.90	6.58	1.32	7.90	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	26.95	5.94	3.18	1.49	2.12	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	45.12	10.13	0.00	1.84	1.84	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.64	8.05	2.98	1.79	0.89	2.09
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	40.24	15.09	1.68	5.03	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.87	9.28	4.52	1.51	2.51	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.24	7.84	2.61	1.19	1.90	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	102.84	21.01	8.29	5.53	6.63	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	31.77	8.98	3.91	1.84	1.38	1.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	25.03	6.94	4.42	2.31	2.94	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	40.56	9.17	7.34	3.26	4.28	2.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	30.68	8.37	3.43	2.36	1.93	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	39.12	9.11	3.33	2.22	3.78	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	82.55	51.59	10.32	0.00	10.32	20.64
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	35.70	8.76	6.13	0.66	3.07	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	54.24	9.63	2.03	2.53	4.06	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	117.65	34.80	6.63	1.66	14.91	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	50.83	19.30	11.69	2.99	5.98	4.35
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	40.00	12.06	7.06	1.47	3.82	2.65
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	109.03	11.99	2.18	3.27	7.63	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.03	4.81	2.40	2.88	1.44	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	37.62	9.61	10.41	2.40	3.20	3.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	98.73	20.57	5.48	12.34	2.74	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	28.03	5.51	3.50	2.50	2.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	73.39	18.35	2.04	4.08	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	34.16	10.07	7.88	3.50	4.82	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	81.67	23.18	0.00	3.31	7.73	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	93.50	28.82	3.84	3.20	7.68	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	38.43	9.67	7.69	2.73	2.23	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	84.20	16.70	1.39	4.18	4.87	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	139.22	39.78	13.26	8.84	13.26	6.63
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	40.34	7.18	2.39	3.42	2.05	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	59.95	12.69	4.38	1.75	5.25	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	110.79	29.12	5.33	3.91	8.88	2.84
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	33.95	8.98	5.61	3.93	3.93	2.52
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	56.94	10.39	4.57	4.57	6.65	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	100.23	27.97	1.75	6.99	10.49	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	40.42	10.26	5.43	2.41	1.51	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	49.25	7.51	4.17	1.25	5.43	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	137.16	21.66	0.00	0.00	14.44	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	51.72	12.01	6.46	1.85	3.69	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	50.65	11.95	3.41	1.71	2.28	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	71.30	16.03	4.15	4.84	4.97	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	31.88	9.33	5.44	2.59	2.85	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	64.35	12.44	3.43	1.29	3.00	3.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	90.20	24.77	3.81	5.72	8.26	1.91
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	56.05	16.28	5.60	5.34	5.07	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	49.99	11.97	2.10	2.99	3.29	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.64	9.89	1.27	3.96	2.54	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	26.44	6.37	1.59	1.27	2.87	2.55
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	44.89	10.17	2.87	1.77	3.98	2.87
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	83.80	22.37	4.55	5.69	4.93	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	39.21	7.10	4.55	3.13	3.98	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.28	5.90	1.72	0.98	2.95	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	95.80	24.76	0.00	2.61	3.91	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	44.10	12.64	2.06	2.94	4.41	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	39.50	8.07	2.59	1.73	2.88	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	71.30	21.43	2.06	4.95	3.71	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	47.65	11.02	2.08	1.79	1.49	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	3.77	0.00	0.00	0.00	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	5.35	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	41.73	12.16	2.63	0.66	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	44.18	4.21	0.00	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	39.73	10.68	0.99	1.78	1.38	1.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	36.32	14.90	0.93	0.93	3.73	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	33.42	11.27	1.88	2.25	1.88	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	26.10	5.33	1.60	0.27	1.60	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	38.23	12.44	1.02	1.13	1.02	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.94	7.37	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	33.71	15.02	0.73	2.20	1.10	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	38.89	12.44	7.78	7.78	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	33.14	11.22	0.53	2.14	1.07	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	10.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	25.30	10.96	1.26	2.53	0.42	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	24.51	2.72	1.36	1.36	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	1.27	1.27	0.64	1.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	13.77	3.24	0.00	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	9.06	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	22.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	6.52	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.62	9.91	3.45	4.31	3.02	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	9.93	5.75	1.05	3.14	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.69	8.68	1.33	2.67	1.33	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.46	6.26	2.09	1.25	2.50	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	17.87	6.27	1.14	2.28	1.14	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	63.83	23.94	1.60	3.19	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.76	3.40	2.04	3.40	0.68	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	20.21	1.84	3.68	9.19	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	5.86	1.26	2.09	2.09	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.32	4.65	1.63	1.16	0.46	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.13	8.11	1.08	2.16	1.35	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	26.49	10.51	1.68	2.10	0.42	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	22.27	0.00	0.00	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.40	1.99	1.99	0.50	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.10	4.33	0.81	1.08	0.00	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.32	4.31	1.36	1.81	0.91	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.50	9.31	1.14	1.96	1.14	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.14	6.93	1.09	2.55	0.73	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	28.64	10.61	0.53	2.12	4.24	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	26.41	4.80	1.20	3.60	2.40	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.36	9.52	1.97	2.95	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.09	9.59	2.28	2.11	2.60	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	51.15	12.17	2.29	5.82	2.12	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	33.05	9.14	4.22	2.11	2.81	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	12.87	6.90	3.22	0.92	4.14	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	33.42	9.00	0.64	2.25	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.83	10.35	1.72	6.21	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	75.85	48.04	2.53	7.59	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.00	14.48	2.67	3.79	3.56	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.98	6.77	1.69	2.54	3.39	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.82	4.27	2.37	1.19	2.61	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	32.62	13.74	1.72	2.15	3.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	63.19	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.66	10.66	1.00	2.33	1.00	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	38.77	8.12	1.80	5.41	3.61	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	18.65	5.56	1.98	1.19	3.57	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	30.65	4.64	1.86	1.86	1.86	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.76	7.57	1.51	1.51	1.51	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.05	11.08	2.61	1.63	1.63	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	44.01	9.59	0.44	2.18	1.31	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	42.51	19.90	1.81	8.14	1.36	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	25.58	8.82	6.17	4.41	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.93	5.98	0.66	1.99	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	37.20	9.42	3.97	3.47	3.47	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	27.56	12.25	3.83	3.83	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.36	8.47	0.91	1.81	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	31.39	9.06	2.43	2.43	1.77	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	33.88	5.42	2.71	4.07	4.74	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	56.20	10.22	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	28.05	10.36	3.05	5.49	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	20.46	5.35	0.63	2.52	3.15	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	25.12	7.87	1.82	3.63	1.21	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	8.70	2.37	1.58	1.58	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	20.41	11.34	5.67	3.40	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	30.35	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	17.76	6.09	0.62	1.61	1.37	0.12
Myoblast, donor2	11322-117D8	17.45	3.84	1.15	2.49	0.96	0.00
Myoblast, donor3	11398-118D3	27.24	8.74	2.86	2.86	2.02	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	8.46	3.21	0.00	1.31	0.00	0.29
Natural Killer Cells, donor1	11230-116C6	32.90	14.76	1.54	3.69	1.54	0.31
Natural Killer Cells, donor2	11311-117C6	24.43	9.95	0.60	3.32	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	21.53	12.33	0.74	1.66	0.74	0.18
Neural stem cells, donor1	11275-116H6	37.02	11.25	9.07	3.63	1.09	1.45
Neural stem cells, donor2	11352-117H2	15.41	7.70	0.00	0.00	1.93	1.93
Neurons, donor1	11494-119E9	9.10	4.55	3.41	2.28	2.28	0.00
Neurons, donor2	11574-120E8	9.69	1.54	1.32	1.54	0.22	0.00
Neurons, donor3	11655-122E8	2.47	0.82	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	8.35	0.00	0.93	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	0.00	0.00	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	23.82	11.00	1.83	4.89	3.67	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	34.31	12.70	1.42	4.63	1.07	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	10.74	3.26	0.00	1.63	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	15.24	6.42	1.60	2.81	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	29.60	7.02	1.79	3.85	1.65	0.96
Olfactory epithelial cells, donor2	11934-125I8	20.41	6.37	2.32	2.75	2.46	0.87
Olfactory epithelial cells, donor3	11935-125I9	19.18	6.58	1.82	2.95	1.82	0.91
Olfactory epithelial cells, donor4	11936-126A1	38.08	12.27	3.21	4.09	2.05	1.36
Oligodendrocyte - precursors, donor1	11496-119F2	38.52	13.24	1.81	4.81	6.02	1.81
Osteoblast - differentiated, donor1	11276-116H7	13.40	4.68	0.64	1.91	0.64	1.06
Osteoblast - differentiated, donor2	11353-117H3	10.29	2.29	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.97	3.10	0.00	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	7.23	2.74	0.39	0.39	0.59	0.00
Osteoblast, donor2	11354-117H4	26.69	6.32	2.11	2.11	2.81	0.70
Osteoblast, donor3	11426-118G4	17.42	6.22	1.24	3.73	2.13	0.53
Pancreatic stromal cells, donor1	11249-116E7	32.68	8.26	1.52	2.78	1.77	0.67
Pericytes, donor1	11491-119E6	3.89	1.89	0.00	1.00	0.56	0.00
Pericytes, donor2	11571-120E5	4.75	2.94	0.23	0.91	0.91	0.23
Pericytes, donor3	11652-122E5	10.58	3.26	1.22	1.22	2.03	0.20
Perineurial Cells, donor1	11499-119F5	23.28	9.38	1.58	3.73	1.92	1.02
Perineurial Cells, donor2	11579-120F4	27.14	9.39	1.84	2.58	1.47	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	65.34	15.94	1.91	3.82	3.82	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	35.75	8.33	1.71	2.94	2.20	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.33	12.68	1.16	3.11	2.46	0.65
Placental Epithelial Cells, donor1	11278-116H9	16.74	6.22	4.07	1.20	1.91	0.96
Placental Epithelial Cells, donor2	11355-117H5	27.72	7.76	9.98	2.22	2.22	5.54
Placental Epithelial Cells, donor3	11427-118G5	13.15	4.12	5.50	2.94	4.71	2.16
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.08	3.16	2.22	0.95	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	28.70	5.44	3.38	2.81	1.69	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.76	10.83	2.48	2.22	1.04	0.52
Preadipocyte - breast, donor2	11328-117E5	19.14	4.28	1.58	1.80	2.25	0.45
Preadipocyte - omental, donor1	11468-119C1	33.99	7.46	3.20	2.88	2.45	0.64
Preadipocyte - omental, donor2	11329-117E6	39.28	12.66	4.36	5.24	1.31	0.87
Preadipocyte - omental, donor3	11403-118D8	27.50	8.31	3.44	3.72	3.01	1.00
Preadipocyte - perirenal, donor1	11469-119C2	18.70	4.92	1.97	1.97	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	10.13	3.99	1.54	0.61	1.23	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	17.18	4.78	3.19	1.95	1.59	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	17.03	3.07	1.87	1.70	1.36	0.34
Preadipocyte - visceral, donor1	11280-116I2	24.13	6.33	2.51	1.86	1.58	1.30
Preadipocyte - visceral, donor2	11357-117H7	18.41	3.68	1.38	3.68	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	12.12	4.28	1.04	1.04	1.36	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	38.47	17.50	10.56	4.83	4.22	2.26
Prostate Epithelial Cells, donor2	11331-117E8	25.73	4.87	4.20	2.84	4.47	1.08
Prostate Epithelial Cells, donor3	11404-118D9	10.90	4.04	0.37	1.29	0.73	0.80
Prostate Stromal Cells, donor1	11254-116F3	21.64	5.58	2.73	3.08	1.82	0.80
Prostate Stromal Cells, donor2	11332-117E9	17.03	3.41	1.97	2.51	1.97	0.72
Prostate Stromal Cells, donor3	11405-118E1	18.04	4.48	1.56	2.50	1.25	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.04	2.92	2.55	0.00	1.09	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.01	10.60	2.77	3.05	3.60	0.97
Renal Epithelial Cells, donor1	11517-119H5	10.14	3.04	2.03	0.00	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	6.40	1.42	0.71	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	38.01	11.43	2.43	3.39	3.18	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.26	1.36	0.00	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.82	2.70	1.08	1.08	1.21	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	30.86	7.10	1.55	2.22	2.44	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.67	0.00	0.67	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.90	2.20	0.22	0.44	0.66	0.66
Renal Mesangial Cells, donor2	11598-120H5	10.66	4.39	0.63	0.63	3.13	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.72	0.83	0.00	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	20.67	6.17	1.61	1.61	1.07	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.28	4.64	0.00	1.27	0.84	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.87	2.31	0.77	0.39	0.96	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	14.78	7.26	2.07	1.04	1.56	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.65	6.25	1.42	1.14	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	2.06	0.00	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.56	4.27	2.51	2.01	1.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	82.19	26.19	11.36	6.82	4.54	2.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	30.38	5.36	0.89	3.57	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.81	3.85	2.20	1.65	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	36.54	9.86	1.16	1.74	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	39.79	8.58	1.43	2.21	0.52	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.43	5.46	0.99	1.79	0.99	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	33.91	7.03	2.01	1.78	1.34	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	33.37	6.95	1.74	1.74	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.03	5.59	1.86	1.63	1.63	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.66	6.47	1.39	1.62	0.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	33.95	7.12	1.92	1.37	0.82	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.30	6.96	1.06	0.91	0.91	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	33.51	8.24	1.97	1.79	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	20.94	6.03	0.86	1.15	0.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.25	5.04	1.61	1.50	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	26.77	2.88	1.33	1.11	0.89	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	33.84	7.07	2.10	0.96	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.23	5.78	1.77	1.58	0.65	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	40.02	6.95	1.69	0.75	0.94	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	37.95	9.95	0.93	2.52	1.33	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.91	6.62	1.27	1.75	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.21	5.73	0.76	1.72	1.53	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	28.73	7.48	1.28	1.82	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.99	4.48	1.12	1.96	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	33.67	6.15	1.37	1.54	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	33.18	4.92	1.09	1.64	1.82	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.87	5.89	0.74	1.47	0.74	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	26.19	4.30	1.21	1.61	0.94	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.35	5.19	1.42	1.18	1.65	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.02	5.16	1.19	0.60	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	25.72	7.25	1.64	1.17	1.64	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	21.15	7.26	1.04	2.28	0.83	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.99	5.53	1.33	1.55	1.33	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.15	6.48	1.67	1.67	2.09	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	25.17	9.02	1.35	1.75	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	33.04	6.64	2.04	1.70	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.04	5.78	1.93	1.74	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.96	6.36	1.38	1.72	0.86	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.22	6.86	1.65	2.06	1.37	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.10	7.22	2.13	2.30	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	28.12	5.28	0.85	1.36	0.68	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	23.67	6.36	1.63	1.33	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	30.39	7.46	1.33	2.67	1.87	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	29.45	5.81	0.83	2.21	0.97	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.29	2.86	0.95	1.19	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	46.35	9.27	1.41	2.82	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.10	6.03	0.85	1.60	0.47	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	16.77	4.54	1.75	2.10	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.06	5.44	1.51	1.81	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	21.17	5.39	0.73	0.98	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	51.23	14.12	2.77	3.35	1.16	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	22.51	6.08	0.00	0.61	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	21.10	6.63	0.00	0.60	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.17	9.27	1.81	1.58	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.84	7.79	2.10	1.80	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	27.51	5.79	1.53	1.53	0.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.97	7.90	1.28	2.99	0.21	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	41.47	11.42	3.61	2.40	0.00	0.00
Schwann Cells, donor1	11498-119F4	6.39	1.69	0.38	1.88	1.13	0.94
Schwann Cells, donor2	11578-120F3	13.61	3.40	0.00	0.00	3.40	3.40
Schwann Cells, donor3	11659-122F3	12.27	4.16	1.10	0.44	1.31	0.00
Sebocyte, donor1	11220-116B5	35.06	8.22	4.38	3.29	6.57	1.10
Sebocyte, donor2	11301-117B5	12.87	3.68	1.84	3.68	3.22	2.30
Sebocyte, donor3	11378-118B1	8.24	3.50	0.21	0.82	0.82	0.82
Sertoli Cells, donor1	11255-116F4	26.51	13.25	1.66	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	28.24	11.30	2.82	2.82	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	16.54	5.81	0.79	1.94	0.79	0.26
Skeletal Muscle Cells, donor2	11358-117H8	7.23	1.45	2.89	2.89	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	3.34	0.00	1.67	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	12.72	3.14	0.94	1.89	1.41	0.00
Skeletal Muscle Cells, donor5	11455-119A6	14.12	4.01	1.64	1.19	0.74	0.45
Skeletal Muscle Cells, donor6	11459-119B1	20.32	5.08	2.15	2.00	2.31	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	32.64	10.33	1.39	2.27	1.01	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	17.98	6.56	0.29	2.28	0.71	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.72	7.34	2.28	3.08	1.49	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.07	5.90	2.70	2.78	2.44	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	3.62	0.00	1.45	0.72	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.49	3.58	0.96	1.65	0.41	0.41
Skin - palm, donor1	10286-104F7	99.39	32.23	8.06	24.17	8.06	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	18.16	5.48	4.32	1.73	4.18	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	80.97	19.63	19.63	4.91	11.45	8.18
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.28	4.80	1.30	0.39	3.89	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	31.69	6.95	4.03	3.34	5.84	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	37.70	11.96	5.34	3.66	7.31	2.67
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	113.33	30.24	9.94	7.82	11.84	2.54
Small Airway Epithelial Cells, donor3	11406-118E2	23.98	8.77	1.87	2.77	1.80	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.32	0.93	0.93	0.31	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	35.13	11.12	3.56	3.56	2.00	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.16	4.11	1.18	3.53	0.59	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.04	2.65	0.66	0.66	1.10	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.84	3.15	0.39	0.39	1.18	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	3.09	0.77	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	31.02	4.00	1.00	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.43	6.52	1.20	2.93	1.06	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.41	3.10	1.77	1.33	1.77	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	24.07	7.68	1.79	2.82	1.92	1.15
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.35	7.16	1.95	2.93	1.95	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	20.38	7.68	1.18	4.43	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.50	7.12	3.13	3.70	2.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.25	0.81	0.49	0.33	0.33	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	23.75	10.66	1.52	5.18	1.22	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.45	6.57	0.51	1.77	1.77	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.92	5.25	1.43	0.95	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	21.97	7.08	1.77	2.80	0.88	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.59	3.01	0.86	3.23	1.08	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.95	4.41	0.63	1.15	1.26	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.29	3.40	2.32	1.39	1.55	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	3.23	1.08	1.08	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.05	4.48	0.90	1.79	1.49	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.22	2.05	0.34	0.00	1.02	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.40	7.30	0.86	1.96	0.71	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	16.30	5.43	2.72	1.81	1.41	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.11	4.55	2.05	2.05	1.37	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.28	1.21	0.00	1.21	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	18.01	5.30	2.12	2.91	0.53	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.90	7.99	0.67	2.66	1.33	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.66	5.63	1.25	1.63	1.75	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.11	5.58	1.78	2.79	2.28	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.41	6.94	3.47	3.77	2.41	1.96
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	4.50	1.50	3.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	6.46	0.00	0.00	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.51	4.19	0.00	4.65	2.33	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.10	1.01	0.50	1.01	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.18	4.70	2.51	1.25	1.25	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.13	0.88	0.00	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	18.49	5.25	1.75	1.75	1.42	1.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.15	7.94	0.00	2.80	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.09	4.89	1.01	2.59	1.44	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.75	4.33	1.53	1.78	1.53	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.97	2.82	1.32	1.13	1.13	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	26.83	6.57	0.84	2.38	1.12	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	30.58	8.55	1.84	3.69	1.84	0.75
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	0.95	0.48	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.99	3.91	0.49	0.98	1.47	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	32.70	7.73	4.42	2.87	2.65	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.60	3.51	0.29	1.76	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.74	7.97	1.55	2.72	0.78	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.21	6.88	3.70	2.38	2.12	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	3.72	1.12	1.12	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.97	5.75	2.16	2.16	2.87	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.19	6.25	1.99	1.14	1.42	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	3.94	1.97	1.18	1.18	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	19.05	5.33	2.29	2.03	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	25.56	6.39	1.20	1.60	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	3.76	0.84	1.67	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	11.92	5.04	0.46	1.38	0.46	1.38
Synoviocyte, donor1	11291-117A4	23.06	8.25	3.20	4.21	2.86	0.17
Synoviocyte, donor2	11368-117I9	13.24	3.86	0.17	1.68	0.00	0.00
Synoviocyte, donor3	11440-118H9	18.99	5.36	0.22	1.56	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	6.07	2.86	0.71	0.00	2.14	2.50
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.80	1.16	0.69	0.69	0.93	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	18.35	5.02	2.37	1.51	2.29	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	12.76	2.71	0.39	1.16	0.00	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	13.17	3.44	0.57	1.72	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	82.43	26.82	13.78	5.29	4.55	1.97
Urethra, donor2	10319-105A4	145.67	39.57	12.59	7.19	3.60	0.00
Urothelial Cells, donor1	11520-119H8	13.28	3.45	1.86	1.06	1.06	2.13
Urothelial Cells, donor2	11600-120H7	13.22	2.40	1.20	0.40	0.80	0.00
Urothelial Cells, donor3	11681-122H7	13.29	2.52	0.92	0.69	1.38	0.69
Urothelial cells, donor0	11216-116B1	49.48	15.83	2.90	4.01	3.79	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	115.67	19.58	3.56	13.35	8.01	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	88.64	10.01	4.29	17.16	10.01	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	52.02	12.32	5.48	6.16	12.32	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	58.88	11.36	5.17	7.92	5.51	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	49.39	15.69	1.16	8.13	2.32	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	109.33	18.74	4.16	12.49	7.29	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	99.12	19.27	7.34	11.01	10.10	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	67.55	7.30	4.56	7.30	6.39	0.91
Wilms' tumor cell line:G-401	10809-111A8	17.76	5.30	1.36	2.47	1.11	0.49
Wilms' tumor cell line:HFWT	10597-108E3	36.96	16.72	7.92	8.80	5.28	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	18.43	5.59	1.68	0.56	0.56	0.28
achilles tendon, donor2	10292-104G4	59.93	20.67	0.00	8.27	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	19.89	4.84	0.00	1.27	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	32.50	4.64	1.16	1.86	1.86	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	67.54	19.71	4.63	4.75	3.09	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	28.57	6.53	0.54	1.63	3.27	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	8.15	3.37	0.56	1.69	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	32.57	4.86	0.42	2.11	1.90	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	53.08	10.07	0.27	2.99	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	20.27	5.73	0.00	1.76	2.64	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	25.32	10.62	0.82	0.41	2.04	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	40.38	6.99	1.55	2.72	3.11	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.80	3.86	0.74	0.74	0.55	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	120.92	31.20	0.00	11.70	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	22.31	6.51	0.46	1.39	2.32	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	24.08	5.70	0.78	0.52	1.29	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	13.74	2.05	0.00	0.58	0.29	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.82	6.97	4.65	1.39	6.97	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	49.35	12.75	1.23	2.06	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	59.86	10.44	6.75	1.84	12.89	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	86.20	16.64	9.81	4.69	11.52	3.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	97.66	16.38	7.89	4.25	11.83	3.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	88.82	11.79	10.59	3.61	12.76	2.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	38.09	6.46	1.34	1.56	1.56	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	23.68	6.34	2.67	3.00	0.67	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	9.29	0.00	3.72	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.35	7.53	2.26	3.77	3.01	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	64.55	13.52	3.93	4.36	6.11	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	44.99	13.12	1.87	3.75	11.25	1.87
adenocarcinoma cell line:IM95m	10796-110I4	103.15	28.73	0.71	4.95	3.53	0.71
adipose tissue, adult, pool1	10010-101C1	92.92	29.63	31.33	6.05	8.22	5.74
adipose, donor1	10184-103D4	36.36	11.73	2.35	3.52	1.76	1.17
adipose, donor2	10185-103D5	8.92	3.24	0.81	0.81	1.62	0.81
adipose, donor3	10186-103D6	14.98	4.36	4.08	2.72	1.09	1.09
adipose, donor4	10187-103D7	11.27	5.20	2.60	0.87	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	48.29	8.84	3.95	1.58	3.16	1.74
adrenal gland, adult, pool1	10081-102A9	25.46	10.91	3.64	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	38.42	8.14	0.93	1.47	0.80	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.88	9.29	5.00	5.00	3.22	1.43
amniotic membrane cells, donor1	12235-129G3	85.55	21.79	11.82	5.33	6.72	3.48
amniotic membrane cells, donor2	12236-129G4	64.58	14.88	21.98	8.11	10.48	5.07
amniotic membrane cells, donor3	12237-129G5	91.33	24.45	9.43	5.01	7.07	4.71
amygdala - adult, donor10196	10167-103B5	15.42	1.19	2.37	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	19.87	11.96	6.08	2.03	1.82	0.61
amygdala, newborn, donor10223	10360-105E9	9.04	7.10	4.20	1.29	1.61	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	39.85	8.15	2.29	1.02	2.16	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	19.19	8.82	1.76	1.76	1.54	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	50.11	15.70	0.33	3.34	0.33	0.33
aorta, adult, pool1	10052-101G7	90.22	30.99	23.73	10.98	6.86	3.53
appendix, adult	10189-103D9	61.71	27.17	6.60	6.99	3.10	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	12.38	3.44	0.34	1.38	0.34	0.34
artery, adult	10190-103E1	38.04	16.30	12.23	2.72	4.08	2.72
astrocytoma cell line:TM-31	10425-106D2	39.40	16.66	2.03	7.39	1.59	0.72
b cell line:RPMI1788	10427-106D4	20.07	4.16	1.93	0.30	1.34	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	27.19	9.71	1.11	4.72	1.39	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	31.95	8.24	3.37	1.89	2.88	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	17.07	7.87	1.67	1.84	0.84	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	13.98	1.68	2.80	2.24	0.00	1.12
bladder, adult, pool1	10011-101C2	112.23	29.01	9.45	5.65	5.87	1.41
blood, adult, pool1	10053-101G8	57.58	2.21	4.43	2.21	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	42.82	7.71	1.71	4.28	0.86	0.86
bone marrow, adult	10192-103E3	58.04	22.94	15.52	2.02	6.75	2.02
brain, adult, donor1	10084-102B3	8.20	9.23	5.13	3.08	1.03	1.03
brain, adult, pool1	10012-101C3	12.81	4.12	3.12	1.00	1.45	0.67
brain, fetal, pool1	10085-102B4	21.37	10.69	0.00	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	49.22	12.55	4.29	2.64	3.63	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	44.81	11.98	2.00	3.00	3.87	2.00
breast, adult, donor1	10080-102A8	67.56	40.41	25.25	5.05	8.84	5.05
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	15.50	2.92	1.02	1.91	1.52	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.28	8.97	0.93	1.86	1.55	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.85	6.91	8.06	2.53	3.45	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	36.56	7.02	2.18	4.36	1.94	1.69
carcinoid cell line:NCI-H1770	10703-109H1	26.80	6.11	0.47	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	27.24	9.41	2.19	3.06	1.31	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	28.84	6.97	1.90	2.85	0.00	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.35	10.91	2.13	1.60	1.86	0.53
caudate nucleus - adult, donor10196	10177-103C6	21.88	10.36	9.21	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	18.07	6.86	6.02	2.18	1.17	0.84
caudate nucleus, adult, donor10258	10379-105H1	8.41	4.58	3.06	0.76	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	10.62	4.39	5.86	1.10	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	17.48	0.00	5.83	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	11.10	5.76	3.20	2.56	0.85	1.07
cerebellum, adult, pool1	10083-102B2	4.14	1.72	1.72	0.00	0.69	1.03
cerebellum, newborn, donor10223	10357-105E6	16.61	10.79	4.15	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	13.62	8.82	6.05	2.02	1.51	1.26
cerebrospinal fluid, donor2	10294-104G6	42.39	12.43	2.92	0.73	3.65	0.73
cervical cancer cell line:D98-AH2	10552-107I3	13.08	5.46	2.44	2.01	0.72	0.72
cervical cancer cell line:ME-180	10553-107I4	22.04	9.61	0.99	3.81	1.33	0.33
cervix, adult, pool1	10013-101C4	88.19	27.51	3.67	5.77	3.36	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.41	6.97	1.53	2.65	0.70	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	79.68	16.98	0.00	5.23	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	96.81	23.36	8.95	5.22	7.83	4.35
choriocarcinoma cell line:SCH	10785-110H2	78.73	20.45	18.61	8.26	15.40	11.21
choriocarcinoma cell line:T3M-3	10618-108G6	64.99	18.97	2.13	2.13	4.74	2.37
chorionic membrane cells, donor1	12238-129G6	75.50	20.51	6.55	6.84	2.56	1.99
chorionic membrane cells, donor2	12239-129G7	58.47	19.19	8.75	6.76	6.96	3.88
chorionic membrane cells, donor3	12240-129G8	92.86	26.92	4.40	8.79	3.85	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	4.04	2.02	0.00	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.86	3.46	0.38	0.77	1.15	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.44	8.66	0.84	3.17	1.69	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	18.23	3.60	1.54	0.51	2.57	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	23.22	2.18	2.90	0.73	1.69	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.36	3.87	3.05	1.22	1.22	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	27.09	3.83	3.24	1.77	1.77	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	24.50	5.99	2.35	4.43	2.87	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	38.40	5.94	2.97	2.51	4.57	1.60
clear cell carcinoma cell line:TEN	10636-108I6	38.87	10.58	1.21	1.39	2.26	1.04
colon carcinoma cell line:CACO-2	10513-107D9	80.72	22.88	12.08	6.41	7.32	3.11
colon carcinoma cell line:COLO-320	10420-106C6	46.37	7.60	0.76	2.28	0.38	0.38
colon, adult, donor1	10082-102B1	39.27	13.09	2.38	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	96.24	36.43	12.57	6.93	5.17	2.12
colon, fetal, donor1	10070-101I7	56.24	24.10	3.71	3.71	3.09	0.62
common myeloid progenitor CMP, donor1	12130-128D6	293.35	73.34	9.17	9.17	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	45.89	10.62	1.70	2.97	1.70	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	30.94	4.98	1.51	1.96	1.36	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	30.32	7.33	0.28	2.26	1.55	0.71
corpus callosum, adult, pool1	10042-101F6	19.79	8.51	8.96	2.32	1.66	1.88
cruciate ligament, donor2	10295-104G7	66.46	20.26	7.29	7.29	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	58.59	20.87	10.43	8.03	3.21	2.41
diencephalon, adult	10193-103E4	7.92	2.64	2.64	1.20	0.96	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.55	4.82	0.46	1.61	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	34.88	8.46	1.03	2.31	0.26	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.17	4.57	1.93	0.96	1.93	1.20
ductus deferens, adult	10196-103E7	117.11	22.92	10.96	6.98	11.96	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	25.92	2.88	5.76	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	68.42	23.54	6.62	4.41	2.94	2.21
dura mater, adult, donor1	10041-101F5	82.26	20.23	14.54	5.45	6.11	5.20
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	17.99	4.44	6.00	2.00	2.66	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.63	4.16	3.73	2.15	2.01	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	76.46	22.81	2.47	8.63	3.08	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	57.82	13.62	7.57	3.63	3.03	1.82
embryonic pancreas cell line:1C3IKEI	10606-108F3	70.39	20.69	2.78	6.48	6.48	1.85
embryonic pancreas cell line:2C6	10603-108E9	81.43	19.70	6.57	6.57	3.94	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	67.71	28.16	2.35	8.72	4.02	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	44.58	11.60	2.54	3.08	1.81	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	14.31	4.18	0.64	1.77	0.96	0.32
epidermoid carcinoma cell line:A431	10426-106D3	48.24	11.56	3.22	3.56	3.56	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.07	5.61	5.61	2.31	3.19	1.87
epididymis, adult	10197-103E8	43.33	15.70	11.30	4.81	2.30	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	64.22	17.74	25.19	4.79	11.89	4.79
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	47.19	16.52	10.22	5.51	3.54	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	16.77	4.06	0.66	0.39	0.66	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	23.52	6.00	0.98	1.28	0.69	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	19.16	3.02	1.34	0.78	0.56	0.34
esophagus, adult, pool1	10015-101C6	57.65	19.22	6.05	4.03	2.23	2.34
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	29.43	15.65	2.50	5.76	1.50	0.50
eye - muscle inferior rectus, donor1	10272-104E2	89.34	36.22	7.24	4.83	16.90	2.41
eye - muscle lateral, donor2	10298-104H1	77.86	14.73	16.83	10.52	8.42	2.10
eye - muscle medial, donor2	10299-104H2	93.76	34.23	2.98	4.46	2.98	2.98
eye - muscle superior, donor2	10297-104G9	81.40	27.52	6.88	5.73	3.44	3.44
eye - vitreous humor, donor1	10268-104D7	30.61	14.57	2.91	2.91	2.91	0.00
eye, fetal, donor1	10054-101G9	20.85	10.68	5.08	3.05	0.25	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	37.31	8.72	2.31	2.18	3.33	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.68	5.94	4.27	1.90	4.27	2.14
frontal lobe, adult, pool1	10040-101F4	10.79	5.72	1.97	1.41	0.75	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	54.65	13.81	4.50	3.90	5.10	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	46.36	12.34	2.83	2.19	2.38	1.19
gall bladder, adult	10198-103E9	54.56	18.35	9.42	5.31	5.79	1.69
gamma delta positive T cells, donor1	11937-126A2	28.45	10.74	1.07	3.22	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	43.70	12.70	1.49	6.35	4.11	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.12	5.91	1.06	2.75	1.69	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	21.66	8.12	0.58	1.93	0.39	0.19
gastric cancer cell line:AZ521	10549-107H9	29.02	9.18	1.97	3.93	1.48	0.98
gastric cancer cell line:GSS	10560-108A2	8.24	4.58	0.92	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.52	14.16	8.68	8.45	2.06	1.83
giant cell carcinoma cell line:LU65	10487-107B1	9.18	2.29	1.72	1.03	0.57	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	27.57	7.56	1.12	0.98	2.38	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	24.69	6.98	0.75	2.00	2.24	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	68.29	16.47	10.45	4.64	5.70	3.38
glioblastoma cell line:A172, tech_rep2	10444-106F3	74.43	18.82	8.43	5.90	5.06	2.11
glioblastoma cell line:T98G	10485-107A8	25.83	6.73	1.99	2.32	1.32	0.77
glioma cell line:GI-1	10413-106B8	43.93	10.25	4.10	6.15	1.76	0.59
globus pallidus - adult, donor10196	10175-103C4	13.85	3.64	8.75	1.46	2.19	1.46
globus pallidus, adult, donor10252	10161-103A8	31.24	7.81	8.30	4.88	2.20	2.44
globus pallidus, adult, donor10258	10367-105F7	5.48	2.74	2.74	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	12.26	3.73	4.80	2.66	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	393.99	66.07	12.24	12.24	9.79	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	36.80	13.12	4.48	3.52	2.24	1.60
hIPS +CCl2, biol_rep1	14383-156B9	13.77	8.26	1.84	1.38	1.84	1.84
hIPS +CCl2, biol_rep2	14384-156C1	15.09	5.94	3.20	0.46	0.46	1.37
hIPS +CCl2, biol_rep3	14385-156C2	19.32	7.09	0.64	1.29	2.58	1.29
hIPS, biol_rep1	14380-156B6	10.06	10.06	0.00	2.87	1.44	0.00
hIPS, biol_rep2	14381-156B7	10.29	8.92	1.37	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	15.45	6.62	3.31	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.87	3.45	0.57	1.15	2.30	1.44
heart - mitral valve, adult	10205-103F7	66.97	22.72	19.43	9.27	8.07	5.08
heart - pulmonic valve, adult	10206-103F8	65.89	21.70	21.70	6.80	5.75	4.18
heart - tricuspid valve, adult	10207-103F9	102.41	33.31	14.99	10.82	5.00	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	38.36	12.65	3.06	3.67	3.26	1.43
heart, adult, diseased, donor1	10051-101G6	25.55	9.37	2.13	2.13	0.85	1.28
heart, adult, pool1	10016-101C7	55.65	19.55	5.75	3.91	2.99	1.38
heart, fetal, pool1	10046-101G1	70.23	27.62	4.93	6.16	1.54	1.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	60.47	18.20	0.93	7.71	2.78	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	115.35	39.24	0.00	9.51	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	31.05	9.72	14.36	3.76	2.76	2.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	30.95	10.56	17.96	4.61	3.28	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	30.82	9.80	16.27	3.13	3.13	2.43
hepatoma cell line:Li-7	10484-107A7	57.16	17.02	6.56	8.79	4.00	1.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.59	5.43	3.22	1.81	1.81	0.50
hippocampus - adult, donor10196	10169-103B7	22.71	6.62	5.68	3.79	2.84	0.95
hippocampus, adult, donor10252	10153-102I9	27.96	10.20	6.94	3.88	1.02	0.41
hippocampus, adult, donor10258	10374-105G5	6.97	3.49	2.99	0.00	0.00	1.49
hippocampus, newborn, donor10223	10363-105F3	12.34	6.70	3.17	1.06	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	21.36	8.54	4.27	1.83	2.44	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	17.08	4.71	3.73	1.57	2.55	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.26	6.60	2.29	2.03	2.54	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	16.35	3.38	2.82	2.82	2.82	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	17.30	5.94	1.29	2.32	1.81	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.40	5.31	1.14	0.38	1.14	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	18.39	5.26	8.17	2.92	3.21	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	17.67	5.17	6.46	2.15	1.29	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	17.93	8.34	6.26	2.50	2.50	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.34	3.79	2.37	1.89	1.42	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	14.46	4.66	3.70	2.09	1.61	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	6.73	3.37	4.04	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.00	4.38	3.13	0.94	2.35	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	16.70	6.88	1.97	2.46	4.42	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.09	6.98	5.24	0.87	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.49	6.87	2.10	1.34	1.91	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.04	6.11	1.74	1.31	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	20.49	8.00	2.00	2.00	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.36	3.77	2.26	1.32	1.51	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.64	5.00	0.91	0.91	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	10.34	4.07	3.45	0.00	0.94	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.00	5.23	2.78	1.63	2.61	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.64	4.35	2.32	2.32	1.74	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	10.16	5.68	1.49	3.29	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.04	5.17	2.77	2.03	1.29	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	17.40	3.14	2.00	1.14	2.28	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	18.78	3.67	5.72	0.82	2.04	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.35	4.22	4.22	1.41	3.52	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	19.32	5.38	4.43	1.58	1.27	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	18.16	5.45	4.84	0.91	1.82	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.93	4.65	2.59	3.10	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	14.61	7.97	1.33	1.33	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	13.85	4.87	3.08	2.31	1.28	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	14.06	3.83	1.53	1.53	2.05	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	5.30	3.79	2.27	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.79	5.04	2.35	2.02	2.02	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	15.46	3.62	3.14	3.14	1.69	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.95	6.68	1.34	2.67	1.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.07	2.93	0.98	1.95	3.41	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	23.84	3.97	2.44	1.53	2.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	87.84	29.28	19.52	3.25	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	20.52	4.30	4.96	1.65	0.66	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.14	2.19	4.38	1.64	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	9.77	1.81	4.34	0.72	1.81	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.10	3.91	4.63	0.36	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	0.00	2.39	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	15.03	6.09	2.30	2.71	1.63	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	13.74	4.04	2.42	2.69	1.08	1.08
immature langerhans cells, donor1	11904-125F5	81.36	16.22	14.77	2.42	11.87	4.12
immature langerhans cells, donor2	11905-125F6	35.65	11.88	7.92	3.96	3.96	2.38
insula, adult, pool1	10039-101F3	14.57	7.67	1.99	1.61	0.28	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	14.31	5.20	0.00	3.90	0.65	0.98
kidney, adult, pool1	10017-101C8	56.77	19.42	13.22	6.41	5.11	3.10
kidney, fetal, pool1	10045-101F9	62.74	25.89	7.92	6.44	2.83	1.56
large cell lung carcinoma cell line:IA-LM	10509-107D5	59.93	26.42	4.12	7.95	3.55	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.05	3.59	0.28	0.28	0.69	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	39.45	11.19	5.87	2.57	5.50	2.94
left atrium, adult, donor1	10079-102A7	27.24	11.44	4.36	5.45	1.63	1.09
left ventricle, adult, donor1	10078-102A6	31.35	12.64	3.54	1.01	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	27.91	8.21	2.74	3.01	1.92	0.82
leiomyoma cell line:10964C	10569-108B2	9.34	3.23	1.80	0.72	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	15.76	3.80	2.72	0.54	1.09	0.54
leiomyoma cell line:15425	10571-108B4	16.27	1.46	2.19	0.49	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	80.51	13.59	6.27	3.14	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	23.02	9.21	1.53	2.60	1.18	0.47
liposarcoma cell line:KMLS-1	10782-110G8	28.12	10.47	2.34	4.06	2.50	0.62
liposarcoma cell line:SW 872	10726-110A6	33.02	9.75	0.85	2.92	1.58	0.61
liver, adult, pool1	10018-101C9	53.32	17.50	6.97	5.02	3.40	0.81
liver, fetal, pool1	10086-102B5	26.34	9.41	5.64	5.64	2.82	0.94
locus coeruleus - adult, donor10196	10182-103D2	28.73	8.46	10.50	2.77	3.50	1.60
locus coeruleus, adult, donor10252	10165-103B3	23.44	7.38	6.83	2.77	1.66	2.40
locus coeruleus, adult, donor10258	10375-105G6	7.34	2.82	5.08	1.69	1.41	0.56
locus coeruleus, newborn, donor10223	10362-105F2	16.40	7.15	5.47	2.52	0.84	2.94
lung adenocarcinoma cell line:A549	10499-107C4	40.83	13.15	3.88	4.29	2.49	1.94
lung adenocarcinoma cell line:PC-14	10408-106B3	56.53	11.03	0.69	2.07	3.45	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	0.00	0.00	0.00	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	86.82	25.99	13.70	5.79	5.91	4.02
lung, fetal, donor1	10068-101I5	159.54	57.94	14.56	16.55	6.85	5.14
lung, right lower lobe, adult, donor1	10075-102A3	52.69	18.33	12.37	6.42	1.83	3.21
lymph node, adult, donor1	10077-102A5	25.09	11.36	1.42	5.68	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	14.25	3.73	0.44	2.63	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.28	6.34	0.00	1.66	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	23.79	6.80	5.10	0.85	0.00	3.40
mature adipocyte, donor1	12231-129F8	169.16	48.39	150.51	8.88	28.86	19.98
mature adipocyte, donor2	12232-129F9	169.76	54.99	141.53	6.64	26.15	25.11
mature adipocyte, donor3	12233-129G1	128.01	41.49	125.64	8.30	23.71	18.73
mature adipocyte, donor4	12234-129G2	142.66	56.59	170.30	10.79	23.69	25.80
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.27	16.44	2.86	7.15	1.43	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	5.64	2.26	2.26	0.00	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	16.37	6.44	5.15	2.94	1.66	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	4.13	2.86	1.27	1.59	0.32	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	18.77	4.26	3.41	1.28	0.43	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	12.32	3.88	3.88	0.68	0.51	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	18.04	9.97	5.09	2.33	1.49	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	9.63	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	12.92	4.67	3.59	1.44	0.36	1.44
medulla oblongata - adult, donor10196	10174-103C3	35.04	11.03	9.09	3.89	2.60	1.30
medulla oblongata, adult, donor10252	10155-103A2	29.10	10.22	9.29	4.33	1.24	1.86
medulla oblongata, adult, pool1	10038-101F2	23.92	7.51	7.26	2.86	1.71	0.73
medulla oblongata, newborn, donor10223	10361-105F1	15.97	6.94	4.51	2.43	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	27.46	7.53	4.43	1.11	4.43	1.33
medulloblastoma cell line:ONS-76	10759-110E3	18.95	5.62	1.10	1.59	1.71	0.49
melanoma cell line:COLO 679	10514-107E1	23.43	6.04	1.29	2.59	0.72	0.86
melanoma cell line:G-361	10465-106H6	16.56	5.97	1.09	1.09	0.54	1.09
meningioma cell line:HKBMM	10691-109F7	17.91	7.06	1.09	0.72	1.45	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	28.20	5.29	1.76	7.93	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	21.00	6.74	2.33	2.59	1.30	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	22.40	5.22	1.99	2.30	1.53	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.18	6.00	2.73	2.36	0.91	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.19	3.31	2.07	0.83	1.66	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.49	3.93	0.28	0.56	0.28	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.71	3.85	1.54	1.54	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	6.25	1.39	3.47	2.08	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.59	4.81	0.17	3.43	0.86	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.36	5.52	1.96	1.84	1.38	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	21.35	5.17	3.18	1.72	1.06	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.91	4.73	2.03	2.03	1.49	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	35.42	11.10	3.27	4.69	1.28	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.49	7.58	0.33	2.31	1.32	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.06	8.86	3.32	2.35	1.38	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.07	8.73	4.89	3.14	2.09	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	26.34	7.96	2.04	3.67	1.63	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.36	7.91	2.88	3.59	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.72	8.48	2.59	4.03	2.59	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.28	7.07	2.05	2.96	0.91	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	26.43	6.71	3.78	3.36	3.36	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.31	4.33	1.34	2.84	1.05	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	32.21	7.88	1.75	2.19	1.66	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.92	12.89	4.42	3.68	4.05	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	29.47	6.01	2.58	3.15	1.14	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.05	3.79	1.68	2.95	2.11	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.07	6.39	0.91	0.00	1.83	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.14	4.35	1.79	2.05	1.28	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.71	5.76	1.83	2.36	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	17.87	4.01	0.92	1.54	1.23	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	17.65	3.06	2.35	1.88	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.86	3.05	1.69	2.71	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.90	5.50	1.96	1.57	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.51	8.34	2.32	2.78	1.85	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.50	5.19	2.02	4.61	1.44	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	19.41	6.25	1.56	2.01	2.01	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.55	2.88	2.16	1.44	1.44	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	33.00	12.47	1.47	2.20	3.67	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.44	7.72	1.68	1.01	0.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.74	4.50	1.64	0.82	2.46	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.75	5.15	2.58	1.72	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	5.47	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	10.33	0.00	0.00	15.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	22.41	6.17	2.27	0.97	3.25	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	5.82	5.82	1.45	4.36	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.19	5.33	1.60	2.13	2.13	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	4.09	1.64	4.09	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	23.71	5.05	4.28	1.55	1.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	4.20	2.10	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	20.86	5.96	5.96	0.99	3.97	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.13	5.93	2.96	1.19	3.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	8.53	4.87	3.66	2.44	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	6.97	8.23	1.90	2.53	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	27.59	7.59	3.10	3.45	2.41	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	0.00	10.75	4.30	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.89	5.30	0.41	1.22	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	14.30	3.18	0.79	3.97	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	15.33	5.31	0.59	2.95	0.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	16.83	6.86	2.18	1.87	0.94	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	6.68	4.01	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	13.01	7.10	1.18	3.55	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	10.27	10.27	10.27	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.09	6.20	3.44	1.38	2.07	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.24	6.93	40.57	4.95	7.92	6.93
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	6.73	33.65	4.49	14.58	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	10.81	29.89	3.18	9.54	6.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	10.88	30.22	4.03	8.06	7.66
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	2.18	13.08	8.72	6.54	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	8.87	29.14	1.27	6.34	6.34
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	55.83	12.74	64.94	6.68	13.35	9.71
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	36.15	85.86	9.04	22.59	22.59
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	45.30	7.41	47.77	7.41	14.83	13.18
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.01	5.36	10.91	2.78	4.17	2.58
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.44	6.81	9.73	1.30	4.22	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	30.56	10.19	10.19	2.04	2.04	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	62.67	14.70	3.09	4.64	2.32	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	113.87	18.43	19.14	7.80	12.52	6.38
mesothelioma cell line:ACC-MESO-4	10494-107B8	42.86	12.97	10.89	3.94	3.48	4.40
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	8.55	17.09	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.90	3.80	3.08	0.62	1.13	0.62
mesothelioma cell line:Mero-25	10850-111F4	10.44	1.59	1.82	1.13	2.04	0.68
mesothelioma cell line:Mero-41	10851-111F5	29.83	9.29	3.18	1.96	2.69	0.98
mesothelioma cell line:Mero-48a	10852-111F6	36.76	7.97	3.10	4.43	2.88	1.77
mesothelioma cell line:Mero-82	10853-111F7	12.35	4.73	1.31	2.37	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	30.64	7.32	14.13	3.40	5.45	3.06
mesothelioma cell line:Mero-84	10855-111F9	37.16	10.11	5.56	3.54	6.57	3.54
mesothelioma cell line:Mero-95	10856-111G1	30.02	8.70	1.45	1.66	3.52	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	22.36	5.14	3.31	1.16	4.80	1.99
mesothelioma cell line:NCI-H226	10846-111E9	45.97	9.59	20.63	3.08	8.69	6.52
mesothelioma cell line:NCI-H2452	10848-111F2	53.64	15.03	12.81	3.93	7.35	4.44
mesothelioma cell line:NCI-H28	10845-111E8	20.87	5.60	4.58	2.04	1.78	1.02
mesothelioma cell line:No36	10857-111G2	30.34	7.50	9.79	1.30	3.26	3.59
mesothelioma cell line:ONE58	10858-111G3	18.15	4.34	1.08	2.44	1.08	1.08
migratory langerhans cells, donor1	11901-125F2	9.02	2.88	0.58	0.38	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	13.68	5.37	0.37	0.24	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	20.10	5.56	0.18	0.36	1.08	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	35.91	7.51	2.61	6.53	1.31	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.32	6.15	2.54	2.33	1.91	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	33.40	11.06	1.15	2.53	1.61	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.79	5.90	0.57	1.90	0.95	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	23.84	6.28	1.11	1.48	1.11	2.22
myeloma cell line:PCM6	10474-106I6	10.67	5.34	0.00	2.77	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.74	16.23	2.54	6.09	3.55	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	38.05	10.00	2.35	2.16	1.57	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.48	4.23	0.33	1.45	0.33	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.81	3.97	0.37	0.59	1.10	0.44
nasal epithelial cells, donor2	12227-129F4	14.90	3.31	0.55	0.00	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	31.52	14.03	2.99	5.52	2.30	1.84
neuroblastoma cell line:NB-1	10539-107G8	104.21	31.80	16.46	15.53	8.98	2.81
neuroblastoma cell line:NBsusSR	10607-108F4	20.88	10.76	0.63	2.95	0.84	0.42
neuroblastoma cell line:NH-12	10555-107I6	41.18	15.84	6.15	3.91	2.80	3.17
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	52.66	12.34	3.56	6.41	1.42	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	34.69	15.68	2.85	5.70	1.11	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	10.67	4.23	0.60	0.81	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	80.74	23.52	2.54	8.26	2.54	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	44.72	15.97	3.46	6.65	3.99	1.33
neutrophil PMN, donor1	12133-128D9	788.36	59.50	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	81.35	16.40	2.88	1.18	5.41	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	24.02	5.60	0.80	3.20	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.52	9.30	5.13	4.49	1.92	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.87	7.09	2.10	3.15	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	13.31	5.16	3.09	2.06	0.66	0.19
occipital cortex - adult, donor10196	10172-103C1	37.09	14.42	2.06	4.12	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	30.86	12.34	6.17	4.83	1.61	0.54
occipital cortex, newborn, donor10223	10355-105E4	16.01	3.28	2.91	0.73	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	9.45	3.15	4.20	2.89	0.26	1.84
occipital lobe, fetal, donor1	10073-102A1	13.73	5.15	2.15	3.00	0.86	1.72
occipital pole, adult, pool1	10036-101E9	11.91	5.44	1.81	1.18	0.55	0.32
olfactory region, adult	10195-103E6	11.27	4.39	3.25	0.76	1.34	1.15
optic nerve, donor1	10277-104E7	42.02	12.01	6.00	4.00	2.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.36	7.29	1.48	2.51	1.14	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.76	7.14	1.24	2.06	0.55	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.38	8.47	2.20	2.37	1.35	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	23.68	8.55	1.16	2.19	1.39	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	47.92	11.17	3.23	3.82	1.47	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	82.22	32.70	2.80	13.08	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	19.51	9.33	1.27	3.82	0.42	0.42
ovary, adult, pool1	10020-101D2	57.91	22.97	11.53	4.72	3.32	3.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	42.35	12.10	2.20	1.83	0.92	1.10
pancreas, adult, donor1	10049-101G4	28.22	13.17	4.70	2.82	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	106.50	25.72	3.63	9.78	11.46	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	29.47	8.01	4.77	3.41	3.07	2.38
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	43.88	17.05	1.66	3.64	1.66	0.66
paracentral gyrus, adult, pool1	10035-101E8	13.00	5.31	2.38	2.11	0.82	0.82
parietal cortex, adult, donor10258	10373-105G4	6.61	1.47	2.20	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	8.46	2.82	0.94	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	20.24	6.84	3.99	3.14	0.00	0.86
parietal lobe, adult, pool1	10034-101E7	11.90	7.31	2.20	1.15	0.35	0.62
parietal lobe, fetal, donor1	10072-101I9	19.40	9.70	1.94	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	15.33	4.86	5.61	1.50	0.37	0.37
parotid gland, adult	10199-103F1	25.90	6.17	5.55	1.85	0.00	0.62
penis, adult	10200-103F2	70.90	24.17	11.82	3.22	4.30	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	40.53	9.48	1.67	2.97	0.37	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	24.77	6.12	2.62	2.91	3.79	1.17
pineal gland - adult, donor10196	10179-103C8	50.96	24.51	10.32	5.81	1.94	3.87
pineal gland, adult, donor10252	10160-103A7	56.85	15.99	7.11	8.29	2.37	0.59
pineal gland, adult, donor10258	10377-105G8	31.98	9.41	14.42	4.39	4.39	2.51
pituitary gland - adult, donor10196	10180-103C9	22.26	12.14	6.07	2.02	2.02	2.02
pituitary gland, adult, donor10252	10162-103A9	33.36	15.11	4.69	4.69	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	9.36	4.26	3.40	3.40	0.85	0.00
placenta, adult, pool1	10021-101D3	66.11	22.90	3.66	5.38	3.12	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	20.13	4.11	0.79	0.79	1.32	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	56.50	18.99	3.27	6.54	1.25	1.09
pons, adult, pool1	10033-101E6	15.49	5.77	3.70	2.15	0.77	0.77
postcentral gyrus, adult, pool1	10032-101E5	10.03	4.71	2.70	1.31	0.44	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	221.69	56.47	0.00	6.27	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	16.61	2.33	1.60	0.44	1.31	1.31
prostate cancer cell line:PC-3	10439-106E7	32.13	6.53	0.36	1.45	1.45	0.36
prostate, adult, pool1	10022-101D4	70.65	20.50	5.71	4.72	2.63	1.72
putamen, adult, donor10196	10176-103C5	11.09	4.96	3.07	0.94	0.24	0.94
putamen, adult, donor10252	10152-102I8	7.84	9.80	0.00	3.92	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	8.74	5.46	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.63	3.38	1.93	0.72	0.97	0.48
putamen, newborn, donor10223	10365-105F5	9.00	2.25	9.00	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	47.13	13.67	0.58	3.78	2.33	0.87
rectum, fetal, donor1	10067-101I4	146.05	44.51	4.17	13.91	6.95	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.73	14.42	3.60	3.60	2.76	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	99.00	16.57	2.07	0.83	2.49	0.41
retina, adult, pool1	10030-101E3	40.95	17.39	13.92	4.17	4.08	2.98
retinoblastoma cell line:Y79	10475-106I7	0.52	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	22.87	9.10	1.35	2.70	1.23	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	65.52	20.25	0.84	5.34	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	71.24	13.64	1.52	4.55	1.52	0.00
salivary acinar cells, donor1	11771-123I7	28.65	5.83	2.27	2.91	2.27	1.13
salivary acinar cells, donor2	11772-123I8	22.99	6.06	2.48	2.48	2.75	1.51
salivary acinar cells, donor3	11773-123I9	82.76	26.48	0.66	9.93	1.99	2.65
salivary gland, adult, pool1	10093-102C3	56.62	18.87	6.29	2.86	2.29	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	37.86	9.02	1.60	3.29	1.18	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	31.27	8.46	1.29	2.70	1.88	0.24
seminal vesicle, adult	10201-103F3	115.34	38.62	12.70	8.99	13.23	5.29
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.25	7.04	7.53	1.94	3.89	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	30.20	6.04	3.27	1.51	2.01	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	8.03	5.02	1.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.60	4.16	0.00	0.94	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	25.31	5.75	1.55	2.21	0.99	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	42.45	13.93	5.42	2.32	2.71	1.55
skeletal muscle - soleus muscle, donor1	10282-104F3	63.13	21.99	17.73	2.84	9.22	8.51
skeletal muscle, adult, pool1	10023-101D5	54.93	19.67	26.03	3.96	4.56	5.40
skeletal muscle, fetal, donor1	10066-101I3	32.16	16.08	5.03	4.02	1.01	0.00
skin, adult, donor1	10074-102A2	54.28	20.36	6.79	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	51.76	27.77	6.31	9.47	5.68	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	20.01	4.34	2.00	3.00	2.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	14.50	5.67	0.32	2.21	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	81.34	13.88	3.66	4.63	4.43	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	80.27	20.77	13.02	8.08	8.57	2.97
small cell lung carcinoma cell line:NCI-H82	10842-111E5	23.16	2.73	1.45	0.97	0.97	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	10.46	3.05	0.00	0.87	0.44	0.00
small intestine, adult, pool1	10024-101D6	156.11	47.06	18.51	10.27	9.91	3.46
small intestine, fetal, donor1	10064-101I1	40.79	16.22	4.42	7.37	0.98	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.98	3.59	0.51	0.51	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	108.55	35.15	12.15	5.94	6.98	3.10
somatostatinoma cell line:QGP-1	10781-110G7	45.83	21.98	1.34	5.90	2.95	0.54
spinal cord - adult, donor10196	10181-103D1	31.89	10.55	14.91	3.21	2.75	3.21
spinal cord, adult, donor10252	10159-103A6	52.04	11.43	18.92	2.76	4.73	7.49
spinal cord, adult, donor10258	10369-105F9	17.99	10.38	4.84	0.00	2.08	2.08
spinal cord, fetal, donor1	10056-101H2	34.76	18.90	10.37	6.10	4.27	2.44
spinal cord, newborn, donor10223	10359-105E8	22.04	11.48	5.05	1.84	1.38	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.40	10.75	3.58	5.08	2.09	1.05
spleen, adult, pool1	10025-101D7	38.44	14.54	1.10	2.75	1.43	0.55
spleen, fetal, pool1	10044-101F8	47.91	15.10	2.07	5.48	1.51	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.70	4.87	1.55	1.55	0.72	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.37	11.77	1.90	1.90	0.95	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	48.92	15.73	3.84	4.89	2.45	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	33.23	10.95	6.65	4.30	6.65	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	21.50	7.20	1.80	3.94	1.46	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.10	4.66	2.54	0.85	2.12	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	49.08	14.81	2.96	2.54	0.42	1.69
stomach, fetal, donor1	10062-101H8	77.96	27.77	4.27	5.34	5.34	0.00
submaxillary gland, adult	10202-103F4	43.30	22.79	5.70	3.99	3.42	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	24.09	6.85	10.59	2.28	1.45	2.08
substantia nigra, adult, donor10258	10371-105G2	14.48	4.14	4.66	0.00	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	28.26	9.19	8.48	1.41	2.12	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	61.67	12.15	1.83	4.13	2.75	0.92
temporal lobe, adult, pool1	10031-101E4	10.00	4.32	2.46	1.02	0.68	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	14.96	9.97	1.42	2.85	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	13.63	4.83	2.64	1.76	0.88	0.44
tenocyte, donor1	11763-123H8	18.85	3.49	1.05	2.44	0.70	0.35
tenocyte, donor2	11765-123I1	22.51	5.34	0.76	2.67	0.76	0.00
tenocyte, donor3	11768-123I4	18.16	1.11	0.74	1.11	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	17.68	6.80	1.53	3.40	1.53	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	18.96	8.02	1.23	1.70	1.23	0.62
teratocarcinoma cell line:PA-1	10807-111A6	42.93	14.10	3.25	7.59	4.96	1.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	53.57	17.52	6.98	9.39	7.11	2.79
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.59	3.40	0.00	2.27	1.13	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	65.11	27.92	1.42	9.49	1.64	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	22.15	9.12	2.28	4.56	2.28	1.95
testis, adult, pool1	10026-101D8	47.89	14.28	14.17	2.90	2.79	2.04
testis, adult, pool2	10096-102C6	36.09	10.37	19.85	2.26	4.06	6.32
thalamus - adult, donor10196	10168-103B6	22.08	5.52	9.94	2.21	2.21	4.42
thalamus, adult, donor10252	10154-103A1	21.72	7.35	6.41	2.03	1.25	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	7.70	6.16	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.08	3.13	3.29	0.33	0.66	0.82
thalamus, newborn, donor10223	10366-105F6	9.78	3.45	4.60	2.88	1.15	0.00
throat, adult	10209-103G2	35.20	11.48	7.24	4.24	2.75	3.00
throat, fetal, donor1	10061-101H7	41.74	15.24	3.96	7.31	2.13	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	22.85	6.56	0.20	1.79	0.99	0.40
thymus, adult, pool1	10027-101D9	61.54	18.29	5.57	6.66	12.03	3.68
thymus, fetal, pool1	10043-101F7	93.51	30.76	5.61	8.94	12.05	1.77
thyroid carcinoma cell line:KHM-5M	10776-110G2	35.37	8.24	3.46	2.53	1.73	1.60
thyroid carcinoma cell line:TCO-1	10783-110G9	33.11	11.87	7.96	3.21	4.05	1.68
thyroid, adult, pool1	10028-101E1	33.31	13.34	2.43	4.11	0.93	0.65
thyroid, fetal, donor1	10060-101H6	28.21	14.77	5.54	4.48	1.58	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	46.19	3.08	12.32	3.08	0.00
tongue, adult	10203-103F5	28.61	6.74	6.51	3.02	2.56	3.26
tongue, fetal, donor1	10059-101H5	29.95	9.46	7.09	3.55	1.18	2.36
tonsil, adult, pool1	10047-101G2	37.67	13.32	1.90	2.60	0.90	0.70
trachea, adult, pool1	10029-101E2	42.37	13.50	3.76	3.44	2.70	0.74
trachea, fetal, donor1	10058-101H4	45.01	16.93	4.62	6.92	0.38	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	28.34	9.92	2.13	3.19	1.42	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	30.90	6.18	2.63	2.03	2.13	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	32.12	7.52	1.10	0.94	1.10	1.10
tridermal teratoma cell line:HGRT	10694-109G1	91.32	19.03	1.90	11.42	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	39.53	18.79	2.88	6.52	3.22	0.51
umbilical cord, fetal, donor1	10057-101H3	33.38	14.61	0.00	8.35	0.00	2.09
uterus, adult, pool1	10100-102D1	125.92	43.85	10.92	5.97	5.97	3.58
uterus, fetal, donor1	10055-101H1	77.81	19.45	5.12	6.14	4.10	2.05
vagina, adult	10204-103F6	96.93	43.94	3.88	5.17	3.88	3.88
vein, adult	10191-103E2	49.98	18.85	19.29	5.92	5.70	4.82
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.95	8.01	0.53	1.07	0.53	0.27

Property "Nearest transcripts" (as page type) with input value "ENST00000425752.6:317 AK310641:317 LF337715:-322 MA573292:-322 LF210415:344 MA445992:344 AK303996:353 ENST00000423947.7:382 AK302819:390 ENST00000680498.1:392 ENST00000320560.13:392 NM_001025356.3:392 NM_001204803.2:392 NM_001142679.2:392 ENST00000550630.5:417 BC098410:417 ENST00000680201.1:437 ENST00000681156.1:447" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.